DNA	O
triplex	O
formation	O
selectively	O
inhibits	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
gene	I-DNA
expression	O
in	O
human	O
T	O
cells	O
.	O

Granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
GM-CSF	B-protein
)	O
is	O
a	O
hemopoietic	O
growth	O
factor	O
that	O
is	O
expressed	O
in	O
activated	O
T	O
cells	O
,	O
fibroblasts	O
,	O
macrophages	O
,	O
and	O
endothelial	O
cells	O
.	O

Although	O
GM-CSF	B-protein
does	O
not	O
appear	O
to	O
be	O
essential	O
for	O
normal	O
hemopoiesis	O
,	O
overexpression	O
of	O
GM-CSF	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
some	O
diseases	O
such	O
as	O
myeloid	O
leukemia	O
and	O
chronic	O
inflammation	O
.	O

An	O
NF-kappaB	B-protein
/Rel	O
binding	O
site	O
within	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
,	O
termed	O
the	O
kappaB	O
element	O
appears	O
to	O
be	O
important	O
for	O
controlling	O
expression	O
in	O
reporter	B-DNA
gene	I-DNA
assays	O
in	O
response	O
to	O
a	O
number	O
of	O
stimuli	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

We	O
investigated	O
oligonucleotide-directed	O
triple	O
helix	O
formation	O
across	O
this	O
regulatory	B-DNA
sequence	I-DNA
as	O
a	O
potential	O
tool	O
to	O
inhibit	O
GM-CSF	B-protein
gene	O
transcription	O
.	O

A	O
15-base	O
oligonucleotide	O
,	O
GM3	O
,	O
was	O
targeted	O
to	O
a	O
purine-rich	B-DNA
region	I-DNA
in	O
the	O
GM-CSF	B-DNA
proximal	I-DNA
promoter	I-DNA
,	O
which	O
overlaps	O
the	O
kappaB	B-DNA
element	I-DNA
.	O

Gel	O
mobility	O
shift	O
assays	O
and	O
DNase	B-protein
I	I-protein
footprinting	O
demonstrated	O
that	O
GM3	O
formed	O
a	O
sequence-specific	O
collinear	O
triplex	O
with	O
its	O
double-stranded	B-DNA
DNA	I-DNA
target	I-DNA
.	O

Triplex	O
formation	O
by	O
GM3	O
blocked	O
recombinant	B-protein
and	I-protein
nuclear	I-protein
NF-kappaB	I-protein
proteins	I-protein
binding	O
to	O
the	O
GM-CSF	B-DNA
element	I-DNA
.	O

GM3	O
also	O
caused	O
selective	O
inhibition	O
of	O
the	O
human	B-protein
T-cell	I-protein
lymphotrophic	I-protein
virus-1	I-protein
Tax	I-protein
transactivator-induced	O
luciferase	B-protein
activity	O
from	O
a	O
reporter	O
construct	O
driven	O
by	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
.	O

Finally	O
,	O
GM3	O
greatly	O
reduced	O
the	O
concentration	O
of	O
endogenous	O
GM-CSF	B-RNA
mRNA	I-RNA
induced	O
by	O
different	O
stimuli	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
but	O
did	O
not	O
affect	O
interleukin	B-RNA
3	I-RNA
mRNA	I-RNA
levels	O
in	O
the	O
same	O
cells	O
.	O

We	O
conclude	O
that	O
the	O
kappaB	B-DNA
element	I-DNA
in	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
plays	O
a	O
central	O
role	O
in	O
the	O
transcriptional	O
activation	O
of	O
the	O
endogenous	O
GM-CSF	B-DNA
gene	I-DNA
.	O

Colinear	O
triplex	O
formation	O
acts	O
as	O
a	O
selective	O
transcriptional	O
repressor	O
of	O
the	O
GM-CSF	B-DNA
gene	I-DNA
and	O
may	O
have	O
potential	O
therapeutic	O
application	O
in	O
cases	O
of	O
undesirable	O
overexpression	O
of	O
this	O
protein	O
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

24	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
14	NULL
,	NULL
pp	NULL
.	NULL

14438-14444	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
DNA	NULL
Triplex	NULL
Formation	NULL
Selectively	NULL
Inhibits	NULL
Granulocyte-Macrophage	NULL
Colony-stimulating	NULL
Factor	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
T	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
12	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
8	NULL
,	NULL
1996	NULL
)	NULL
Marina	NULL
Kochetkova	NULL
and	NULL
M.	NULL
Frances	NULL
Shannont	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Human	NULL
Immunology	NULL
,	NULL
Hanson	NULL
Centre	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
and	NULL
Veterinary	NULL
Science	NULL
,	NULL
Frome	NULL
Road	NULL
,	NULL
Adelaide	NULL
5000	NULL
,	NULL
South	NULL
Australia	NULL
,	NULL
Australia	NULL
Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
is	NULL
a	NULL
hemopoietic	NULL
growth	NULL
factor	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
fibroblasts	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
.	NULL

Although	NULL
GM-CSF	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
normal	NULL
hemopoiesis	NULL
,	NULL
overexpression	NULL
of	NULL
GM-CSF	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
some	NULL
diseases	NULL
such	NULL
as	NULL
myeloid	NULL
leukemia	NULL
and	NULL
chronic	NULL
inflammation	NULL
.	NULL

An	NULL
NF-	NULL
«	NULL
B/Rel	NULL
binding	NULL
site	NULL
within	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
,	NULL
termed	NULL
the	NULL
xB	NULL
element	NULL
appears	NULL
to	NULL
be	NULL
important	NULL
for	NULL
controlling	NULL
expression	NULL
in	NULL
reporter	NULL
gene	NULL
assays	NULL
in	NULL
response	NULL
to	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
investigated	NULL
oligonucleotide-directed	NULL
triple	NULL
helix	NULL
formation	NULL
across	NULL
this	NULL
regulatory	NULL
sequence	NULL
as	NULL
a	NULL
potential	NULL
tool	NULL
to	NULL
inhibit	NULL
GM-CSF	NULL
gene	NULL
transcription	NULL
.	NULL

A	NULL
15-base	NULL
oligonucleotide	NULL
,	NULL
GM3	NULL
,	NULL
was	NULL
targeted	NULL
to	NULL
a	NULL
purine-rich	NULL
region	NULL
in	NULL
the	NULL
GM-CSF	NULL
proximal	NULL
promoter	NULL
,	NULL
which	NULL
overlaps	NULL
the	NULL
xB	NULL
element	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
demonstrated	NULL
that	NULL
GM3	NULL
formed	NULL
a	NULL
sequence-specific	NULL
collinear	NULL
triplex	NULL
with	NULL
its	NULL
double-stranded	NULL
DNA	NULL
target	NULL
.	NULL

Triplex	NULL
formation	NULL
by	NULL
GM3	NULL
blocked	NULL
recombinant	NULL
and	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
GM-CSF	NULL
element	NULL
.	NULL

GM3	NULL
also	NULL
caused	NULL
selective	NULL
inhibition	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
lymphotrophic	NULL
virus-1	NULL
Tax	NULL
transactivator-in-duced	NULL
luciferase	NULL
activity	NULL
from	NULL
a	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Fi-nally	NULL
,	NULL
GM3	NULL
greatly	NULL
reduced	NULL
the	NULL
concentration	NULL
of	NULL
endogenous	NULL
GM-CSF	NULL
mRNA	NULL
induced	NULL
by	NULL
different	NULL
stimuli	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
interleukin	NULL
3	NULL
mRNA	NULL
levels	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
xB	NULL
element	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
endogenous	NULL
GM-CSF	NULL
gene	NULL
.	NULL

Colinear	NULL
triplex	NULL
formation	NULL
acts	NULL
as	NULL
a	NULL
selective	NULL
transcriptional	NULL
repressor	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
and	NULL
may	NULL
have	NULL
potential	NULL
therapeutic	NULL
application	NULL
in	NULL
cases	NULL
of	NULL
undesirable	NULL
overexpression	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

Cytokines	NULL
are	NULL
a	NULL
rapidly	NULL
growing	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
act	NULL
as	NULL
local	NULL
or	NULL
systemic	NULL
intercellular	NULL
regulatory	NULL
factors	NULL
.	NULL

They	NULL
are	NULL
involved	NULL
in	NULL
various	NULL
developmental	NULL
and	NULL
differential	NULL
processes	NULL
and	NULL
are	NULL
important	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
to	NULL
infection	NULL
and	NULL
injury	NULL
.	NULL

However	NULL
,	NULL
cytokines	NULL
are	NULL
also	NULL
implicated	NULL
in	NULL
the	NULL
pathology	NULL
of	NULL
many	NULL
clinical	NULL
conditions	NULL
including	NULL
septic	NULL
shock	NULL
,	NULL
parasitic	NULL
infec-tions	NULL
,	NULL
chronic	NULL
inflammation	NULL
,	NULL
atherosclerosis	NULL
,	NULL
and	NULL
cancer	NULL
(	NULL
1	NULL
)	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
National	NULL
Health	NULL
and	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Australia	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
}	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Div	NULL
.	NULL

of	NULL
Human	NULL
Immunology	NULL
,	NULL
Institute	NULL
of	NULL
Medical	NULL
and	NULL
Veterinary	NULL
Science	NULL
,	NULL
Box	NULL
14	NULL
,	NULL
Rundle	NULL
Mall	NULL
,	NULL
P.O	NULL
.	NULL

,	NULL
Adelaide	NULL
,	NULL
5000	NULL
South	NULL
Australia	NULL
,	NULL
Australia	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
61	NULL
8	NULL
222	NULL
3475	NULL
;	NULL
Fax	NULL
:	NULL
61	NULL
8	NULL
282	NULL
4092	NULL
;	NULL
E-mail	NULL
:	NULL
fshannon	NULL
@	NULL
immuno.imvs.sa.gov.au	NULL
.	NULL

Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
is	NULL
a	NULL
cytokine	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
survival	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
functional	NULL
activation	NULL
of	NULL
mature	NULL
myeloid	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

2	NULL
)	NULL
.	NULL

GM-CSF	NULL
``	NULL
expression	NULL
occurs	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
fibroblasts	NULL
and	NULL
endothelial	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
proinflamma-tory	NULL
agents	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
monocytes	NULL
in	NULL
response	NULL
to	NULL
endotoxin	NULL
,	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
clinical	NULL
application	NULL
of	NULL
GM-CSF	NULL
as	NULL
an	NULL
activator	NULL
of	NULL
hemopoietic	NULL
cell	NULL
production	NULL
after	NULL
bone	NULL
marrow	NULL
transplantation	NULL
,	NULL
evidence	NULL
has	NULL
accumulated	NULL
to	NULL
suggest	NULL
that	NULL
GM-CSF	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
several	NULL
disease	NULL
conditions	NULL
,	NULL
in	NULL
particular	NULL
myeloid	NULL
leukemia	NULL
and	NULL
chronic	NULL
inflammation	NULL
(	NULL
4-7	NULL
)	NULL
.	NULL

GM-CSF	NULL
was	NULL
found	NULL
to	NULL
be	NULL
abnormally	NULL
expressed	NULL
in	NULL
atopic	NULL
patients	NULL
and	NULL
in	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

In	NULL
terms	NULL
of	NULL
leukemia	NULL
,	NULL
GM-CSF	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
produced	NULL
by	NULL
some	NULL
leukemic	NULL
clones	NULL
in	NULL
an	NULL
autocrine	NULL
fashion	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
the	NULL
growth	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
vitro	NULL
depends	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Recent	NULL
in	NULL
vivo	NULL
experiments	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
GM-CSF	NULL
increased	NULL
the	NULL
blast	NULL
cell	NULL
counts	NULL
in	NULL
9	NULL
of	NULL
12	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
patients	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
it	NULL
would	NULL
be	NULL
of	NULL
significant	NULL
therapeutic	NULL
importance	NULL
to	NULL
be	NULL
able	NULL
to	NULL
modulate	NULL
GM-CSF	NULL
gene	NULL
expression	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
are	NULL
attracting	NULL
increasing	NULL
interest	NULL
as	NULL
tools	NULL
for	NULL
specific	NULL
manipulation	NULL
of	NULL
gene	NULL
expression	NULL
and	NULL
have	NULL
potential	NULL
therapeutic	NULL
application	NULL
.	NULL

Several	NULL
strategies	NULL
that	NULL
employ	NULL
short	NULL
nucleic	NULL
acid	NULL
fragments	NULL
targeted	NULL
to	NULL
different	NULL
intracel-lular	NULL
components	NULL
are	NULL
currently	NULL
under	NULL
investigation	NULL
with	NULL
variable	NULL
success	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

10	NULL
)	NULL
.	NULL

The	NULL
``	NULL
antigene	NULL
``	NULL
(	NULL
11	NULL
)	NULL
strategy	NULL
is	NULL
based	NULL
on	NULL
inhibition	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
selected	NULL
gene	NULL
by	NULL
oligonucleotide-directed	NULL
intermolecular	NULL
DNA	NULL
triple	NULL
helix	NULL
formation	NULL
either	NULL
through	NULL
prevention	NULL
of	NULL
regulatory	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
control	NULL
regions	NULL
(	NULL
12	NULL
)	NULL
or	NULL
by	NULL
acting	NULL
as	NULL
transcriptional	NULL
repressors	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Triplex	NULL
formation	NULL
may	NULL
have	NULL
certain	NULL
advantages	NULL
over	NULL
the	NULL
other	NULL
oligonucleotide-mediated	NULL
strategies	NULL
,	NULL
as	NULL
there	NULL
are	NULL
fewer	NULL
target	NULL
molecules	NULL
per	NULL
cell	NULL
and	NULL
it	NULL
is	NULL
expected	NULL
to	NULL
be	NULL
more	NULL
selective	NULL
.	NULL

In	NULL
vitro	NULL
experiments	NULL
demonstrated	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
such	NULL
sequence-specific	NULL
structures	NULL
can	NULL
inhibit	NULL
DNA	NULL
replication	NULL
(	NULL
14	NULL
)	NULL
or	NULL
block	NULL
transcription	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
gene	NULL
of	NULL
interest	NULL
and	NULL
thereby	NULL
directly	NULL
affect	NULL
transcription	NULL
initiation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Triplex-forming	NULL
oligonucleotides	NULL
(	NULL
TFOs	NULL
)	NULL
were	NULL
also	NULL
found	NULL
to	NULL
repress	NULL
transcription	NULL
in	NULL
intact	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
highly	NULL
specific	NULL
inhibition	NULL
of	NULL
the	NULL
synthesis	NULL
of	NULL
promoter	NULL
reporter	NULL
gene	NULL
targets	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

Predominantly	NULL
polypurine	NULL
:	NULL
polypyrimidine	NULL
(	NULL
Pur	NULL
:	NULL
Pyr	NULL
)	NULL
se	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GM-CSF	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
TFO	NULL
,	NULL
triplex-forming	NULL
oligonu-cleotides	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
HTLV	NULL
,	NULL
human	NULL
T-cell	NULL
lymphotrophic	NULL
virus	NULL
.	NULL

14438	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Repression	NULL
of	NULL
GM-CSF	NULL
Transcription	NULL
by	NULL
DNA	NULL
Triple	NULL
Helix	NULL
quences	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
suitable	NULL
targets	NULL
for	NULL
intermolecular	NULL
triple	NULL
helices	NULL
.	NULL

Different	NULL
structures	NULL
of	NULL
base	NULL
triplets	NULL
have	NULL
been	NULL
described	NULL
,	NULL
forming	NULL
two	NULL
groups	NULL
of	NULL
DNA	NULL
triple	NULL
helices	NULL
.	NULL

Both	NULL
have	NULL
the	NULL
third	NULL
strand	NULL
binding	NULL
in	NULL
the	NULL
major	NULL
groove	NULL
of	NULL
the	NULL
duplex	NULL
DNA	NULL
through	NULL
Hoogsteen	NULL
(	NULL
Y*RY	NULL
motif	NULL
)	NULL
or	NULL
reverse	NULL
Hoogsteen	NULL
(	NULL
R*RY	NULL
motif	NULL
)	NULL
base	NULL
pairing	NULL
.	NULL

The	NULL
best	NULL
studied	NULL
Y*RY	NULL
type	NULL
,	NULL
formed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
polypyrimidine	NULL
third	NULL
strand	NULL
,	NULL
consists	NULL
of	NULL
C**G	NULL
:	NULL
C	NULL
and	NULL
T*A	NULL
:	NULL
T	NULL
base	NULL
triads	NULL
with	NULL
the	NULL
third	NULL
strand	NULL
parallel	NULL
to	NULL
the	NULL
purine-rich	NULL
strand	NULL
of	NULL
the	NULL
underlying	NULL
duplex	NULL
(	NULL
19	NULL
,	NULL
20	NULL
)	NULL
.	NULL

These	NULL
triplexes	NULL
are	NULL
stable	NULL
only	NULL
under	NULL
acidic	NULL
pH	NULL
,	NULL
but	NULL
that	NULL
condition	NULL
can	NULL
be	NULL
partly	NULL
overcome	NULL
by	NULL
methylation	NULL
of	NULL
the	NULL
third	NULL
strand	NULL
cytosines	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Stable	NULL
R*RY	NULL
type	NULL
triplexes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
form	NULL
at	NULL
physiological	NULL
pH	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
divalent	NULL
cations	NULL
,	NULL
where	NULL
oligonucleotide	NULL
interaction	NULL
with	NULL
double-stranded	NULL
DNA	NULL
involves	NULL
G*G	NULL
:	NULL
C	NULL
,	NULL
A*A	NULL
:	NULL
T	NULL
,	NULL
or	NULL
T*A	NULL
:	NULL
T	NULL
triads	NULL
with	NULL
an	NULL
antiparallel	NULL
orientation	NULL
of	NULL
the	NULL
third	NULL
strand	NULL
(	NULL
21	NULL
)	NULL
.	NULL

TFO	NULL
binding	NULL
to	NULL
the	NULL
DNA	NULL
duplex	NULL
target	NULL
appears	NULL
to	NULL
be	NULL
highly	NULL
sequence-specific	NULL
,	NULL
as	NULL
triplex-forming	NULL
oligos	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
recognize	NULL
unique	NULL
sites	NULL
in	NULL
the	NULL
yeast	NULL
chromosome	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
human	NULL
GM-CSF	NULL
gene	NULL
contains	NULL
an	NULL
enhancer	NULL
located	NULL
approximately	NULL
3	NULL
kilobases	NULL
from	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
24	NULL
)	NULL
and	NULL
a	NULL
proximal	NULL
promoter	NULL
spanning	NULL
at	NULL
least	NULL
the	NULL
first	NULL
120	NULL
bp	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
3	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
tightly	NULL
regulated	NULL
by	NULL
induction	NULL
and	NULL
binding	NULL
of	NULL
multiple	NULL
transcription	NULL
factors	NULL
including	NULL
NF-	NULL
«	NULL
B/Rel	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NFAT	NULL
proteins	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

The	NULL
GM-CSF	NULL
promoter	NULL
contains	NULL
two	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
the	NULL
CK-1	NULL
element	NULL
,	NULL
which	NULL
binds	NULL
only	NULL
specific	NULL
members	NULL
of	NULL
the	NULL
family	NULL
such	NULL
as	NULL
p65	NULL
(	NULL
Rel-A	NULL
)	NULL
and	NULL
c-Rel	NULL
(	NULL
Rel	NULL
)	NULL
,	NULL
and	NULL
the	NULL
«	NULL
B	NULL
element	NULL
that	NULL
binds	NULL
mainly	NULL
classical	NULL
NF-	NULL
«	NULL
B	NULL
p65/p50	NULL
(	NULL
NF-kB1	NULL
)	NULL
complexes	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
xB	NULL
element	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
response	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
to	NULL
T	NULL
cell	NULL
receptor	NULL
type	NULL
signals	NULL
as	NULL
well	NULL
as	NULL
HTLV-1	NULL
Tax	NULL
activation	NULL
in	NULL
T-cells	NULL
(	NULL
25	NULL
,	NULL
27	NULL
)	NULL
Here	NULL
we	NULL
attempted	NULL
to	NULL
modulate	NULL
transcription	NULL
from	NULL
the	NULL
GM-CSF	NULL
gene	NULL
by	NULL
DNA	NULL
triple	NULL
helix	NULL
formation	NULL
within	NULL
the	NULL
promoter	NULL
region	NULL
.	NULL

A	NULL
triplex-forming	NULL
oligodeoxynucleotide	NULL
was	NULL
targeted	NULL
to	NULL
a	NULL
15-bp	NULL
purine-rich	NULL
sequence	NULL
that	NULL
overlaps	NULL
the	NULL
«	NULL
B-element	NULL
.	NULL

Sequence	NULL
specificity	NULL
of	NULL
the	NULL
third	NULL
strand	NULL
coupling	NULL
to	NULL
its	NULL
duplex	NULL
target	NULL
was	NULL
investigated	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
ability	NULL
of	NULL
triplex	NULL
formation	NULL
to	NULL
inhibit	NULL
recombinant	NULL
and	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

We	NULL
also	NULL
evaluated	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
triplex-forming	NULL
oligomer	NULL
on	NULL
luciferase	NULL
activity	NULL
from	NULL
GM-CSF	NULL
promoter-driven	NULL
reporter	NULL
constructs	NULL
and	NULL
on	NULL
endogenous	NULL
GM-CSF	NULL
mRNA	NULL
and	NULL
immunoreactive	NULL
protein	NULL
levels	NULL
in	NULL
activated	NULL
Jukart	NULL
T-cells	NULL
and	NULL
show	NULL
that	NULL
triplex	NULL
formation	NULL
can	NULL
selectively	NULL
suppress	NULL
human	NULL
GM-CSF	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Oligonucleotides	NULL
and	NULL
Plasmids-Oligodeoxyribonucleotides	NULL
were	NULL
synthesized	NULL
by	NULL
the	NULL
B-cyanocethylphosphoramidite	NULL
method	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
synthesizer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
solid	NULL
support	NULL
for	NULL
nonmodified	NULL
oligomers	NULL
or	NULL
solid	NULL
support	NULL
coupled	NULL
with	NULL
3'-amino-modifier	NULL
(	NULL
Glen	NULL
Research	NULL
,	NULL
Sterling	NULL
,	NULL
VA	NULL
)	NULL
for	NULL
oligomers	NULL
with	NULL
a	NULL
propanolamine	NULL
group	NULL
at	NULL
the	NULL
3	NULL
``	NULL
terminus	NULL
.	NULL

Deprotected	NULL
oligonucleotides	NULL
were	NULL
purified	NULL
by	NULL
preparative	NULL
12-20	NULL
%	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Concentrations	NULL
were	NULL
determined	NULL
by	NULL
absorption	NULL
measurements	NULL
at	NULL
260	NULL
nm	NULL
using	NULL
molar	NULL
extinction	NULL
coefficients	NULL
.	NULL

Oligonucleotide	NULL
sequences	NULL
are	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

16	NULL
.	NULL

The	NULL
HTLV-1	NULL
tax	NULL
expression	NULL
plasmid	NULL
(	NULL
pcTax	NULL
)	NULL
used	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Warner	NULL
Greene	NULL
(	NULL
Gladstone	NULL
Institute	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
construct	NULL
pGMluc	NULL
contains	NULL
620	NULL
bp	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
pIL3luc	NULL
,	NULL
containing	NULL
a	NULL
670-bp	NULL
(	NULL
-550	NULL
to	NULL
+120	NULL
)	NULL
polymerase	NULL
chain	NULL
reaction	NULL
fragment	NULL
of	NULL
human	NULL
IL-3	NULL
gene	NULL
promoter	NULL
made	NULL
using	NULL
AJ1-16	NULL
genomic	NULL
clone	NULL
(	NULL
24	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
Peter	NULL
Cockerill	NULL
(	NULL
IMVS	NULL
,	NULL
Adelaide	NULL
,	NULL
S.A.	NULL
,	NULL
Australia	NULL
)	NULL
.	NULL

Triplex	NULL
Gel	NULL
Shift	NULL
Assays-Double-stranded	NULL
oligodeoxyribonucleo-tides	NULL
were	NULL
end-labeled	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
°PJATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

TFOs	NULL
(	NULL
specific	NULL
and	NULL
control	NULL
)	NULL
were	NULL
heated	NULL
at	NULL
65	NULL
°C	NULL
for	NULL
5	NULL
min	NULL
to	NULL
prevent	NULL
self-association	NULL
and	NULL
placed	NULL
on	NULL
ice	NULL
.	NULL

Triplex	NULL
formation	NULL
was	NULL
assessed	NULL
by	NULL
14439	NULL
incubating	NULL
for	NULL
2	NULL
h	NULL
at	NULL
20	NULL
°C	NULL
0.2	NULL
ng	NULL
of	NULL
double-stranded	NULL
probe	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
TFOs	NULL
(	NULL
see	NULL
legend	NULL
for	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
in	NULL
89	NULL
mM	NULL
Tris	NULL
borate	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
10	NULL
%	NULL
sucrose	NULL
followed	NULL
by	NULL
electrophoresis	NULL
through	NULL
a	NULL
12	NULL
%	NULL
native	NULL
acrylamide	NULL
gel	NULL
for	NULL
16	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Both	NULL
gel	NULL
and	NULL
running	NULL
buffer	NULL
contained	NULL
89	NULL
mM	NULL
Tris	NULL
borate	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
and	NULL
20	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
.	NULL

DNase	NULL
I	NULL
Footprinting	NULL
Analysis-The	NULL
probe	NULL
for	NULL
DNase	NULL
I	NULL
footprinting	NULL
was	NULL
prepared	NULL
by	NULL
digesting	NULL
the	NULL
pGMluc	NULL
plasmid	NULL
with	NULL
Sail	NULL
,	NULL
dephospho-rylated	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
,	NULL
and	NULL
radiolabeling	NULL
with	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

After	NULL
a	NULL
second	NULL
digest	NULL
with	NULL
Mscl	NULL
the	NULL
489-bp	NULL
probe	NULL
was	NULL
purified	NULL
on	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
.	NULL

Triplex	NULL
formation	NULL
reactions	NULL
were	NULL
performed	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
described	NULL
for	NULL
the	NULL
triplex	NULL
band	NULL
shift	NULL
assays	NULL
and	NULL
were	NULL
then	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
unit/pl	NULL
for	NULL
30	NULL
s.	NULL
Digestion	NULL
was	NULL
stopped	NULL
by	NULL
adding	NULL
20	NULL
mM	NULL
EDTA	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
.	NULL

A	NULL
+	NULL
G	NULL
chemical	NULL
sequencing	NULL
of	NULL
the	NULL
probe	NULL
was	NULL
carried	NULL
out	NULL
according	NULL
to	NULL
the	NULL
Maxam-Gilbert	NULL
method	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
electrophoresed	NULL
through	NULL
6	NULL
%	NULL
denaturing	NULL
gels	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
visualized	NULL
using	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
.	NULL

Protein	NULL
Binding	NULL
Assay-Triplex	NULL
formation	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
using	NULL
*°P-end-labeled	NULL
double-stranded	NULL
fragments	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
promoter	NULL
and	NULL
immunoglobulin	NULL
x	NULL
gene	NULL
enhancer	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

After	NULL
initial	NULL
incubation	NULL
for	NULL
triplex	NULL
formation	NULL
of	NULL
approximately	NULL
0.2	NULL
ng	NULL
of	NULL
the	NULL
probe	NULL
with	NULL
specific	NULL
or	NULL
control	NULL
single-stranded	NULL
oligonucleotides	NULL
as	NULL
described	NULL
above	NULL
recombinant	NULL
p65	NULL
(	NULL
27	NULL
)	NULL
or	NULL
nuclear	NULL
extracts	NULL
from	NULL
transfected	NULL
and	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
prepared	NULL
according	NULL
to	NULL
Ref	NULL
.	NULL

30	NULL
)	NULL
were	NULL
added	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
30	NULL
min	NULL
at	NULL
20	NULL
°C	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
the	NULL
protein	NULL
binding	NULL
buffer	NULL
was	NULL
25	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.6	NULL
)	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
60	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
for	NULL
the	NULL
recombinant	NULL
p65	NULL
.	NULL

Ten	NULL
mM	NULL
MgCl	NULL
,	NULL
was	NULL
also	NULL
present	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
for	NULL
the	NULL
nuclear	NULL
proteins	NULL
.	NULL

Electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
on	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
containing	NULL
0.25	NULL
x	NULL
TBE	NULL
buffer	NULL
at	NULL
190	NULL
V	NULL
for	NULL
90	NULL
min	NULL
for	NULL
samples	NULL
with	NULL
the	NULL
recombinant	NULL
p65	NULL
and	NULL
0.5	NULL
x	NULL
TGE	NULL
buffer	NULL
at	NULL
150	NULL
V	NULL
for	NULL
3	NULL
h	NULL
using	NULL
nuclear	NULL
extracts	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Transfection	NULL
Procedure-The	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
was	NULL
cultured	NULL
in	NULL
RPMI	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
supplemented	NULL
with	NULL
L-glutamine	NULL
and	NULL
penicillin/gentamycin	NULL
antibiotics	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
at	NULL
270	NULL
V	NULL
and	NULL
a	NULL
capacitance	NULL
of	NULL
960	NULL
microfarads	NULL
using	NULL
a	NULL
Bio-Rad	NULL
gene	NULL
pulser	NULL
.	NULL

5	NULL
X	NULL
10°	NULL
cells	NULL
in	NULL
350	NULL
ul	NULL
of	NULL
RPMI	NULL
containing	NULL
20	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
were	NULL
used	NULL
per	NULL
transfection	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
HTLV-1	NULL
tax	NULL
expression	NULL
vector	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
pGMluc	NULL
or	NULL
plL	NULL
&	NULL
lue	NULL
reporter	NULL
plasmid	NULL
was	NULL
used	NULL
per	NULL
transfection	NULL
.	NULL

Twenty-four	NULL
hours	NULL
post-transfection	NULL
,	NULL
TFO	NULL
GMS	NULL
or	NULL
control	NULL
oligonucleotide	NULL
GMc	NULL
was	NULL
added	NULL
(	NULL
where	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
)	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
2	NULL
h	NULL
,	NULL
stimulated	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
20	NULL
ng/ml	NULL
PMA	NULL
and	NULL
2	NULL
uM	NULL
calcium	NULL
ionophore	NULL
,	NULL
and	NULL
harvested	NULL
8	NULL
h	NULL
later	NULL
.	NULL

Luciferase	NULL
Reporter	NULL
Assay	NULL
and	NULL
RNA	NULL
Analysis-Cells	NULL
used	NULL
for	NULL
the	NULL
luciferase	NULL
reporter	NULL
assay	NULL
were	NULL
activated	NULL
and	NULL
exposed	NULL
to	NULL
oligonucleotides	NULL
as	NULL
described	NULL
above	NULL
and	NULL
lysed	NULL
by	NULL
three	NULL
freeze/thaw	NULL
rounds	NULL
8	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
PMA/Ca®*	NULL
ionophore	NULL
.	NULL

Three	NULL
ug	NULL
of	NULL
total	NULL
protein	NULL
from	NULL
the	NULL
cell	NULL
lysates	NULL
was	NULL
used	NULL
per	NULL
luciferase	NULL
assay	NULL
according	NULL
to	NULL
a	NULL
procedure	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Light	NULL
emission	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
scintillation	NULL
counter	NULL
with	NULL
the	NULL
coincidence	NULL
circuit	NULL
switched	NULL
off	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
,	NULL
treated	NULL
with	NULL
oligonucleotides	NULL
(	NULL
where	NULL
indicated	NULL
)	NULL
,	NULL
and	NULL
activated	NULL
with	NULL
PMA/Ca®*	NULL
ionophore	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
purified	NULL
using	NULL
guanidine	NULL
isothiocyanate	NULL
8	NULL
h	NULL
after	NULL
cell	NULL
stimulation	NULL
.	NULL

The	NULL
method	NULL
for	NULL
quantitating	NULL
specific	NULL
mRNA	NULL
by	NULL
RNase	NULL
protection	NULL
and	NULL
the	NULL
vectors	NULL
for	NULL
antisense	NULL
RNA	NULL
synthesis	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
82	NULL
)	NULL
.	NULL

Ten	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
used	NULL
for	NULL
each	NULL
assay	NULL
with	NULL
°°P-labeled	NULL
antisense	NULL
probe	NULL
.	NULL

Specific	NULL
bands	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
and	NULL
normalized	NULL
against	NULL
glyc-eraldehyde-3-phosphate	NULL
dehydrogenase	NULL
as	NULL
internal	NULL
control	NULL
.	NULL

Assessment	NULL
of	NULL
the	NULL
GM-CSF	NULL
Protein	NULL
Levels	NULL
in	NULL
the	NULL
Culture	NULL
Medium-The	NULL
concentration	NULL
of	NULL
GM-CSF	NULL
protein	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
the	NULL
cell	NULL
samples	NULL
,	NULL
used	NULL
for	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
quantified	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
Quantikine	NULL
R	NULL
&	NULL
0	NULL
Systems	NULL
Inc.	NULL
,	NULL
Minne-apolis	NULL
,	NULL
MN	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
detection	NULL
limit	NULL
for	NULL
this	NULL
assay	NULL
was	NULL
1.5	NULL
pg/ml	NULL
.	NULL

RESULTS	NULL
Oligonucleotide	NULL
Design	NULL
and	NULL
Triplex	NULL
Formation	NULL
on	NULL
the	NULL
GM-CSF	NULL
Promoter-It	NULL
was	NULL
previously	NULL
shown	NULL
that	NULL
triple	NULL
helix	NULL
formation	NULL
by	NULL
oligonucleotides	NULL
can	NULL
inhibit	NULL
DNA-protein	NULL
interaction	NULL
at	NULL
specific	NULL
regions	NULL
by	NULL
only	NULL
overlapping	NULL
and	NULL
not	NULL
spanning	NULL
the	NULL
entire	NULL
protein	NULL
binding	NULL
site	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
15-bp	NULL
sequence	NULL
from	NULL
-80	NULL
to	NULL
-65	NULL
,	NULL
which	NULL
overlaps	NULL
the	NULL
kB	NULL
element	NULL
in	NULL
the	NULL
GM-CSF	NULL
gene	NULL
proximal	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1a	NULL
)	NULL
was	NULL
targeted	NULL
to	NULL
form	NULL
an	NULL
intermo-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
14440	NULL
triplex	NULL
target	NULL
sequence	NULL
5'-TPCCCCCGCCTcccTt	NULL
3	NULL
'-AMGGGGGCGCGAGGGA	NULL
NFEATETS	NULL
vag	NULL
_|	NULL
'	NULL
1	NULL
:	NULL
)	NULL
~100	NULL
xB	NULL
-65	NULL
AP1	NULL
B	NULL
GM	NULL
5	NULL
-orrcai	NULL
3	NULL
'	NULL
-CaAacTECcAF®E	NULL
Igs	NULL
CeacceccaTer-s	NULL
'	NULL
'	NULL
5	NULL
``	NULL
-TTGGGGGGGGTGqeT-3	NULL
'	NULL
GMc	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

The	NULL
GM-CSF	NULL
proximal	NULL
promoter	NULL
(	NULL
4	NULL
)	NULL
and	NULL
oligode-oxynucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Map	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
proximal	NULL
promoter	NULL
with	NULL
previously	NULL
identified	NULL
functionally	NULL
important	NULL
elements	NULL
or	NULL
conserved	NULL
elements	NULL
shown	NULL
by	NULL
shaded	NULL
boxes	NULL
.	NULL

The	NULL
15-bp	NULL
target	NULL
site	NULL
(	NULL
-80	NULL
to	NULL
-65	NULL
)	NULL
for	NULL
triplex	NULL
formation	NULL
is	NULL
indicated	NULL
.	NULL

An	NULL
arrow	NULL
indicates	NULL
the	NULL
transcription	NULL
initiation	NULL
point	NULL
.	NULL

B	NULL
,	NULL
GM	NULL
is	NULL
a	NULL
30-mer	NULL
from	NULL
-90	NULL
to	NULL
-60	NULL
in	NULL
the	NULL
GM-CSF	NULL
gene	NULL
promoter	NULL
used	NULL
as	NULL
a	NULL
duplex	NULL
target	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

The	NULL
underlined	NULL
sequence	NULL
indicates	NULL
the	NULL
region	NULL
targeted	NULL
for	NULL
triplex	NULL
formation	NULL
with	NULL
a	NULL
point	NULL
of	NULL
``	NULL
mismatch	NULL
``	NULL
shown	NULL
in	NULL
small	NULL
capitals	NULL
.	NULL

Igk	NULL
is	NULL
a	NULL
27-mer	NULL
(	NULL
3981-3957	NULL
)	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
site	NULL
from	NULL
the	NULL
immunoglobulin	NULL
x	NULL
gene	NULL
enhancer	NULL
used	NULL
as	NULL
a	NULL
control	NULL
duplex	NULL
.	NULL

Shaded	NULL
in	NULL
both	NULL
double-stranded	NULL
oligomers	NULL
are	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
GM3	NULL
oligonucleotide	NULL
was	NULL
designed	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
target	NULL
site	NULL
as	NULL
a	NULL
third	NULL
strand	NULL
,	NULL
and	NULL
GMc	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
oligonucleotide	NULL
.	NULL

lecular	NULL
triple	NULL
helix	NULL
.	NULL

This	NULL
sequence	NULL
contains	NULL
only	NULL
one	NULL
``	NULL
mismatch	NULL
``	NULL
in	NULL
an	NULL
otherwise	NULL
Pur	NULL
:	NULL
Pyr	NULL
tract	NULL
and	NULL
is	NULL
72	NULL
%	NULL
G-rich	NULL
,	NULL
properties	NULL
that	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
stable	NULL
triplex	NULL
formation	NULL
.	NULL

A	NULL
triplex-forming	NULL
oligonucleotide	NULL
GM3	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
was	NULL
designed	NULL
according	NULL
to	NULL
the	NULL
rules	NULL
previously	NULL
described	NULL
in	NULL
numerous	NULL
studies	NULL
(	NULL
17	NULL
,	NULL
33-35	NULL
)	NULL
,	NULL
i.e	NULL
.	NULL

T	NULL
opposite	NULL
A	NULL
:	NULL
T	NULL
pairs	NULL
and	NULL
G	NULL
opposite	NULL
G	NULL
:	NULL
C	NULL
pairs	NULL
with	NULL
its	NULL
orientation	NULL
antiparallel	NULL
to	NULL
the	NULL
purine	NULL
strand	NULL
of	NULL
the	NULL
underlying	NULL
duplex	NULL
target	NULL
.	NULL

G	NULL
was	NULL
also	NULL
put	NULL
opposite	NULL
the	NULL
interrupting	NULL
C	NULL
:	NULL
G	NULL
pair	NULL
,	NULL
as	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
tolerated	NULL
in	NULL
this	NULL
triplex	NULL
motif	NULL
(	NULL
17	NULL
,	NULL
33	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
an	NULL
oligomer	NULL
GMe	NULL
of	NULL
random	NULL
sequence	NULL
of	NULL
G	NULL
and	NULL
T	NULL
residues	NULL
with	NULL
the	NULL
same	NULL
length	NULL
as	NULL
GM3	NULL
was	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
these	NULL
oligonucleotides	NULL
to	NULL
form	NULL
triplexes	NULL
was	NULL
analyzed	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

A	NULL
radiolabeled	NULL
30-bp	NULL
fragment	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
from	NULL
-90	NULL
to	NULL
-60	NULL
(	NULL
GM	NULL
,	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
,	NULL
which	NULL
encompassed	NULL
the	NULL
TFO	NULL
target	NULL
and	NULL
overlapping	NULL
xB	NULL
element	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
the	NULL
GM3	NULL
oligonucleotide	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Mg**	NULL
and	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
also	NULL
containing	NULL
Mg**	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

Triplex	NULL
formation	NULL
was	NULL
concentration-dependent	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
but	NULL
occurred	NULL
only	NULL
at	NULL
the	NULL
higher	NULL
concentrations	NULL
of	NULL
specific	NULL
TFO	NULL
and	NULL
with	NULL
apparent	NULL
K	NULL
,	NULL
,	NULL
>	NULL
10	NULL
um	NULL
.	NULL

However	NULL
no	NULL
triplex	NULL
formation	NULL
was	NULL
observed	NULL
when	NULL
control	NULL
GMe	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
with	NULL
GM	NULL
even	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

GM3	NULL
was	NULL
also	NULL
incubated	NULL
with	NULL
a	NULL
control	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
«	NULL
B	NULL
element	NULL
from	NULL
the	NULL
immunoglobulin	NULL
«	NULL
gene	NULL
(	NULL
Igk	NULL
)	NULL
,	NULL
and	NULL
no	NULL
triplex	NULL
formation	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
the	NULL
selectivity	NULL
and	NULL
specificity	NULL
of	NULL
the	NULL
GM3	NULL
TFO	NULL
,	NULL
a	NULL
DNase	NULL
I	NULL
footprinting	NULL
assay	NULL
was	NULL
performed	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
that	NULL
triplex	NULL
formation	NULL
by	NULL
GM3	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
diges-tion	NULL
,	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
,	NULL
only	NULL
the	NULL
targeted	NULL
sequence	NULL
of	NULL
15	NULL
bp	NULL
within	NULL
a	NULL
489-bp	NULL
Sall/Mscl	NULL
fragment	NULL
of	NULL
the	NULL
Repression	NULL
of	NULL
GM-CSF	NULL
Transcription	NULL
by	NULL
DNA	NULL
Triple	NULL
Helix	NULL
Duplex	NULL
target	NULL
MGM	NULL
IgK	NULL
.	NULL

Oligonucleotide	NULL
GM3	NULL
GMc	NULL
-	NULL
GM3	NULL
T	NULL
-	NULL
>	NULL
@	NULL
CBB	NULL
am	NULL
»	NULL
ene	NULL
<	NULL
=	NULL
>	NULL
p	NULL
-	NULL
>	NULL
¥	NULL
«	NULL
o	NULL
am	NULL
<	NULL
-	NULL
©	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
triplex	NULL
formation	NULL
.	NULL

End-labeled	NULL
duplexes	NULL
(	NULL
~0.2	NULL
ng	NULL
)	NULL
,	NULL
GM	NULL
,	NULL
and	NULL
Igx	NULL
were	NULL
preincubated	NULL
alone	NULL
(	NULL
Zanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
or	NULL
with	NULL
GMS	NULL
at	NULL
10	NULL
pM	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
,	NULL
3	NULL
and	NULL
1	NULL
uM	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
or	NULL
GMc	NULL
at	NULL
10	NULL
pM	NULL
(	NULL
Fane	NULL
4	NULL
)	NULL
and	NULL
assayed	NULL
by	NULL
electrophoresis	NULL
through	NULL
a	NULL
native	NULL
12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
for	NULL
18	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Arrows	NULL
show	NULL
the	NULL
mobility	NULL
of	NULL
double-stranded	NULL
(	NULL
D	NULL
)	NULL
and	NULL
triple-stranded	NULL
(	NULL
T	NULL
)	NULL
DNA	NULL
.	NULL

GMs	NULL
Oligonucleotide	NULL
_	NULL
--	NULL
--	NULL
--	NULL
--	NULL
GMC	NULL
Cone	NULL
(	NULL
uM	NULL
)	NULL
TI	NULL
Cee	NULL
&	NULL
g	NULL
L	NULL
oT	NULL
T	NULL
T	NULL
o	NULL
``	NULL
~	NULL
A	NULL
A	NULL
G	NULL
G	NULL
G	NULL
4	NULL
a	NULL
s	NULL
B	NULL
m	NULL
#	NULL
G	NULL
C	NULL
G	NULL
G	NULL
A	NULL
G	NULL
=	NULL
#	NULL
B	NULL
=	NULL
;	NULL
G	NULL
a	NULL
rei	NULL
fel	NULL
le	NULL
A	NULL
f	NULL
8	NULL
#	NULL
im	NULL
&	NULL
is	NULL
*	NULL
k	NULL
2	NULL
£	NULL
%	NULL
res	NULL
*	NULL
&	NULL
4	NULL
%	NULL
:	NULL
'	NULL
am	NULL
.	NULL

1°	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
specificity	NULL
of	NULL
triplex	NULL
formation	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

A	NULL
489-bp	NULL
fragment	NULL
of	NULL
GM-CSF	NULL
gene	NULL
promoter	NULL
,	NULL
``	NULL
P-labeled	NULL
at	NULL
one	NULL
end	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
TFO	NULL
GM3	NULL
or	NULL
control	NULL
oligonucleotide	NULL
(	NULL
GMc	NULL
at	NULL
the	NULL
concentrations	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
followed	NULL
by	NULL
DNase	NULL
I	NULL
digestion	NULL
.	NULL

For	NULL
the	NULL
control	NULL
DNase	NULL
I	NULL
digest	NULL
,	NULL
the	NULL
promoter	NULL
fragment	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
oligonucleotides	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

A	NULL
G	NULL
+	NULL
A	NULL
Maxam-Gilbert	NULL
sequencing	NULL
reaction	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
was	NULL
run	NULL
beside	NULL
DNase	NULL
I	NULL
digests	NULL
to	NULL
precisely	NULL
map	NULL
the	NULL
DNase	NULL
I	NULL
footprint	NULL
.	NULL

The	NULL
target	NULL
sequence	NULL
for	NULL
triplex	NULL
formation	NULL
by	NULL
GM3	NULL
is	NULL
indicated	NULL
in	NULL
brackets	NULL
.	NULL

GM-CSF	NULL
gene	NULL
promoter	NULL
.	NULL

The	NULL
DNase	NULL
I	NULL
footprint	NULL
occurred	NULL
at	NULL
4	NULL
uM	NULL
concentration	NULL
of	NULL
the	NULL
specific	NULL
TFO	NULL
,	NULL
and	NULL
full	NULL
protection	NULL
was	NULL
obtained	NULL
at	NULL
16	NULL
um	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
affinity	NULL
of	NULL
GM3	NULL
for	NULL
its	NULL
target	NULL
duplex	NULL
observed	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
nonspecific	NULL
oligomer	NULL
GMc	NULL
did	NULL
not	NULL
allow	NULL
any	NULL
protection	NULL
of	NULL
the	NULL
target	NULL
from	NULL
DNase	NULL
I-mediated	NULL
degradation	NULL
even	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
20	NULL
um	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
oligonucleotide	NULL
GM3	NULL
forms	NULL
a	NULL
stable	NULL
and	NULL
sequence-selective	NULL
triple	NULL
helix	NULL
with	NULL
its	NULL
double-stranded	NULL
target	NULL
from	NULL
the	NULL
GM-CSF	NULL
gene	NULL
proximal	NULL
promoter	NULL
.	NULL

Inhibition	NULL
of	NULL
Transcription	NULL
Factor	NULL
Binding	NULL
by	NULL
Triplex-forming	NULL
Oligonucleotides-The	NULL
effect	NULL
of	NULL
triplex	NULL
formation	NULL
by	NULL
GM3	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
«	NULL
B	NULL
element	NULL
within	NULL
the	NULL
30-bp	NULL
fragment	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
was	NULL
examined	NULL
by	NULL
gel	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

The	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
increasing	NULL
concentration	NULL
of	NULL
GM3	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
recombinant	NULL
p65	NULL
protein	NULL
or	NULL
nuclear	NULL
extracts	NULL
from	NULL
HTLV-1	NULL
Tax-expressing	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
the	NULL
recombinant	NULL
p65-DNA	NULL
complex	NULL
was	NULL
inhibited	NULL
by	NULL
TFO	NULL
GM3	NULL
in	NULL
a	NULL
concentration-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

40	NULL
)	NULL
.	NULL

The	NULL
GMc	NULL
un-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Repression	NULL
of	NULL
GM-CSF	NULL
Transcription	NULL
by	NULL
DNA	NULL
Triple	NULL
Helix	NULL
A	NULL
Competitor	NULL
-	NULL
E	NULL
,	NULL
-	NULL
oe	NULL
-	NULL
L	NULL
Lo	NULL
!	NULL

Probe	NULL
gM	NULL
&	NULL
GM	NULL
P	NULL
Oligonucleotide	NULL
e	NULL
GM3	NULL
CMc	NULL
GM3	NULL
Pés	NULL
-P	NULL
-	NULL
swe	NULL
Free	NULL
probe	NULL
.	NULL

-	NULL
>	NULL
can	NULL
aun	NULL
agp	NULL
<	NULL
>	NULL
<	NULL
Gb	NULL
-	NULL
ou	NULL
GHD	NULL
:	NULL
100	NULL
20	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
io	NULL
B	NULL
Competitor	NULL
-	NULL
-	NULL
&	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
Probe	NULL
am	NULL
_-	NULL
Igx	NULL
GM	NULL
Oligonucleotide	NULL
|	NULL
L	NULL
-	NULL
.	NULL

0	NULL
.	NULL

-_	NULL
C	NULL
--	NULL
SWS	NULL
___	NULL
cme	NULL
#	NULL
#	NULL
im	NULL
ms	NULL
NF-kB/rel	NULL
__	NULL
.	NULL

#	NULL
old	NULL
bos	NULL
awp	NULL
<	NULL
==	NULL
Activation	NULL
N/S	NULL
tax	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
triplex	NULL
formation	NULL
on	NULL
recombinant	NULL
(	NULL
4	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
B	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
GM-CSF	NULL
gene	NULL
promoter	NULL
fragment	NULL
containing	NULL
the	NULL
«	NULL
B-element	NULL
.	NULL

A	NULL
,	NULL
effect	NULL
of	NULL
the	NULL
TFO	NULL
GM3	NULL
on	NULL
the	NULL
binding	NULL
to	NULL
DNA	NULL
of	NULL
purified	NULL
recombinant	NULL
truncated	NULL
p65	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
pG5-DNA	NULL
complex	NULL
and	NULL
unbound	NULL
free	NULL
probes	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
on	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
using	NULL
°P	NULL
-labeled	NULL
double-stranded	NULL
DNA	NULL
fragments	NULL
from	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
GM	NULL
)	NULL
and	NULL
immunoglobulin	NULL
k	NULL
gene	NULL
enhancer	NULL
(	NULL
Igx	NULL
)	NULL
containing	NULL
the	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
.	NULL

Double-stranded	NULL
probes	NULL
(	NULL
~0.2	NULL
ng	NULL
)	NULL
were	NULL
preincubated	NULL
alone	NULL
or	NULL
with	NULL
oligonucleotides	NULL
at	NULL
the	NULL
following	NULL
concentrations	NULL
:	NULL
GM3	NULL
at	NULL
10	NULL
uM	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
10	NULL
)	NULL
,	NULL
3	NULL
,	NULL
1	NULL
,	NULL
0.3	NULL
,	NULL
and	NULL
0.1	NULL
uM	NULL
(	NULL
lanes	NULL
5-8	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
GMe	NULL
at	NULL
10	NULL
uM	NULL
(	NULL
Zane	NULL
9	NULL
)	NULL
followed	NULL
by	NULL
further	NULL
incubation	NULL
with	NULL
recombinant	NULL
p65	NULL
.	NULL

B	NULL
,	NULL
triplex	NULL
formation	NULL
by	NULL
GM8	NULL
inhibits	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
DNA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
nonstimulated	NULL
(	NULL
N/S	NULL
)	NULL
or	NULL
HTLV-1	NULL
Tax	NULL
expressing	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
tax	NULL
)	NULL
.	NULL

An	NULL
arrow	NULL
indicates	NULL
the	NULL
xB-like	NULL
DNA-protein	NULL
complex	NULL
.	NULL

Mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
for	NULL
the	NULL
recombinant	NULL
p65	NULL
,	NULL
except	NULL
that	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
were	NULL
used	NULL
.	NULL

TFO	NULL
and	NULL
control	NULL
oligomer	NULL
were	NULL
added	NULL
to	NULL
the	NULL
double-stranded	NULL
probes	NULL
at	NULL
the	NULL
following	NULL
concentrations	NULL
:	NULL
GM3	NULL
at	NULL
10	NULL
pM	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
3	NULL
,	NULL
1	NULL
,	NULL
and	NULL
0.3	NULL
uM	NULL
(	NULL
lanes	NULL
6-8	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
GMc	NULL
at	NULL
10	NULL
uM	NULL
(	NULL
Fane	NULL
9	NULL
)	NULL
The	NULL
figure	NULL
shows	NULL
only	NULL
the	NULL
region	NULL
of	NULL
the	NULL
gel	NULL
containing	NULL
inducible	NULL
«	NULL
B-like	NULL
DNA-protein	NULL
complex	NULL
and	NULL
some	NULL
constitutive	NULL
DNA-protein	NULL
complexes	NULL
with	NULL
similar	NULL
electrophoretic	NULL
mobility	NULL
.	NULL

Identification	NULL
of	NULL
specific	NULL
DNA-NF-	NULL
«	NULL
B	NULL
complexes	NULL
was	NULL
performed	NULL
by	NULL
competition	NULL
with	NULL
20	NULL
ng	NULL
of	NULL
unlabeled	NULL
Igx	NULL
in	NULL
both	NULL
assays	NULL
(	NULL
panel	NULL
A	NULL
,	NULL
lane	NULL
2	NULL
,	NULL
and	NULL
panel	NULL
B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

related	NULL
oligomer	NULL
that	NULL
could	NULL
not	NULL
form	NULL
a	NULL
triplex	NULL
did	NULL
not	NULL
have	NULL
any	NULL
significant	NULL
effect	NULL
on	NULL
p65	NULL
interaction	NULL
with	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

40	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

p65	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
Igx	NULL
control	NULL
probe	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
the	NULL
GM3-specific	NULL
oligonucleotide	NULL
,	NULL
used	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
(	NULL
Fig	NULL
.	NULL

40	NULL
,	NULL
lane	NULL
10	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
HTLV-1	NULL
tax	NULL
expression	NULL
plasmid	NULL
contain	NULL
NF-	NULL
«	NULL
B/Rel	NULL
complexes	NULL
that	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
GM-CSF	NULL
«	NULL
B	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
)	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
cold	NULL
Igx	NULL
oligomer	NULL
containing	NULL
the	NULL
«	NULL
kB	NULL
consensus	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Several	NULL
constitutive	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
also	NULL
detected	NULL
under	NULL
the	NULL
conditions	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

45	NULL
)	NULL
.	NULL

Preincubation	NULL
of	NULL
the	NULL
probe	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
GM3	NULL
inhibited	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
«	NULL
B-DNA	NULL
specific	NULL
complex	NULL
in	NULL
a	NULL
concentration	NULL
14441	NULL
120	NULL
C	NULL
&	NULL
1	NULL
Ja	NULL
~	NULL
]	NULL
I	NULL
Relative	NULL
transcriptional	NULL
activation	NULL
(	NULL
%	NULL
)	NULL
0	NULL
Oligonucleotide	NULL
_	NULL
Nil	NULL
GMs	NULL
GMec	NULL
Conc	NULL
(	NULL
uM	NULL
)	NULL
0.5	NULL
1	NULL
1	NULL
@	NULL
-	NULL
pGMIluc	NULL
plL3luc	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
TFOs	NULL
on	NULL
the	NULL
transcriptional	NULL
activation	NULL
from	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
containing	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
genes	NULL
promoters	NULL
.	NULL

pGMluc	NULL
,	NULL
pIL3luc	NULL
,	NULL
and	NULL
expression	NULL
plasmid	NULL
pcTax	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

Five	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
was	NULL
co-transfected	NULL
by	NULL
electroporation	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
together	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
peTax	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
GM3	NULL
,	NULL
or	NULL
GMc	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
.	NULL

Columns	NULL
show	NULL
relative	NULL
levels	NULL
of	NULL
transcriptional	NULL
induction	NULL
upon	NULL
stimulation	NULL
from	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
reporter	NULL
gene	NULL
activities	NULL
in	NULL
transfected	NULL
cells	NULL
stimulated	NULL
by	NULL
overexpression	NULL
of	NULL
Tax	NULL
and	NULL
treated	NULL
with	NULL
only	NULL
medium	NULL
were	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
100	NULL
%	NULL
.	NULL

Tax	NULL
expression	NULL
lead	NULL
to	NULL
an	NULL
average	NULL
of	NULL
250-fold	NULL
induction	NULL
for	NULL
pGMIlue	NULL
and	NULL
223-fold	NULL
induction	NULL
for	NULL
plL	NULL
&	NULL
lue	NULL
over	NULL
the	NULL
level	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

Columns	NULL
and	NULL
error	NULL
bars	NULL
on	NULL
the	NULL
graph	NULL
(	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL
)	NULL

represent	NULL
combined	NULL
data	NULL
from	NULL
seven	NULL
measurements	NULL
in	NULL
three	NULL
independent	NULL
experiments	NULL
for	NULL
pGMluc	NULL
and	NULL
five	NULL
measurements	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
for	NULL
plL3luc	NULL
.	NULL

dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

45	NULL
,	NULL
lanes	NULL
5-8	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
effect	NULL
was	NULL
detected	NULL
with	NULL
control	NULL
GMc	NULL
oligomer	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
triplex	NULL
formation	NULL
specifically	NULL
prevents	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
(	NULL
either	NULL
recombinant	NULL
or	NULL
nuclear	NULL
proteins	NULL
)	NULL
to	NULL
the	NULL
«	NULL
B	NULL
element	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
promoter	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
constitutive	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
GM	NULL
fragment	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
were	NULL
also	NULL
blocked	NULL
by	NULL
the	NULL
related	NULL
TFO	NULL
but	NULL
not	NULL
by	NULL
the	NULL
control	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

46	NULL
)	NULL
.	NULL

This	NULL
fact	NULL
could	NULL
be	NULL
viewed	NULL
as	NULL
additional	NULL
evidence	NULL
that	NULL
the	NULL
observed	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
DNA	NULL
probe	NULL
was	NULL
due	NULL
to	NULL
triplex	NULL
formation	NULL
at	NULL
the	NULL
targeted	NULL
site	NULL
and	NULL
not	NULL
TFO-NF-	NULL
«	NULL
B	NULL
protein	NULL
interactions	NULL
.	NULL

Inhibition	NULL
of	NULL
Transcription	NULL
from	NULL
GM-CSF	NULL
Promoter	NULL
Reporter	NULL
Constructs-It	NULL
was	NULL
shown	NULL
previously	NULL
(	NULL
17	NULL
,	NULL
36	NULL
)	NULL
that	NULL
short	NULL
single-stranded	NULL
oligonucleotides	NULL
,	NULL
when	NULL
applied	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
,	NULL
can	NULL
internalize	NULL
into	NULL
cells	NULL
and	NULL
equilibrate	NULL
the	NULL
concentration	NULL
inside	NULL
and	NULL
outside	NULL
the	NULL
cell	NULL
membrane	NULL
within	NULL
a	NULL
few	NULL
hours	NULL
.	NULL

This	NULL
phenomenon	NULL
is	NULL
not	NULL
universal	NULL
and	NULL
varies	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
used	NULL
in	NULL
the	NULL
experiment	NULL
possibly	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
different	NULL
mechanisms	NULL
of	NULL
oligonucleotide	NULL
uptake	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

37	NULL
)	NULL
.	NULL

When	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
intrinsically	NULL
°°P-labeled	NULL
oligonucleotide	NULL
we	NULL
also	NULL
found	NULL
that	NULL
the	NULL
intra-cellular	NULL
concentration	NULL
of	NULL
the	NULL
oligomer	NULL
reached	NULL
approximately	NULL
50	NULL
%	NULL
of	NULL
that	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
after	NULL
2	NULL
h	NULL
and	NULL
approximately	NULL
80	NULL
%	NULL
after	NULL
5	NULL
h	NULL
of	NULL
incubation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
effect	NULL
of	NULL
triplex	NULL
formation	NULL
on	NULL
GM-CSF	NULL
gene	NULL
transcription	NULL
in	NULL
cell	NULL
culture	NULL
,	NULL
3'-amino-derivatized	NULL
(	NULL
specific	NULL
and	NULL
control	NULL
)	NULL
oligomers	NULL
were	NULL
directly	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

3'-modification	NULL
with	NULL
a	NULL
primary	NULL
amino	NULL
group	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
significantly	NULL
increase	NULL
the	NULL
resistance	NULL
of	NULL
natural	NULL
phosphodiester	NULL
oligode-	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
14442	NULL
oxynucleotides	NULL
to	NULL
nuclease	NULL
degradation	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Two	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
were	NULL
used	NULL
to	NULL
analyze	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
TFO	NULL
to	NULL
inhibit	NULL
inducible	NULL
transcriptional	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
620-bp	NULL
GM-CSF	NULL
promoter	NULL
reporter	NULL
vector	NULL
(	NULL
pGMluc	NULL
)	NULL
containing	NULL
the	NULL
triplex	NULL
target	NULL
site	NULL
and	NULL
a	NULL
plasmid	NULL
with	NULL
670	NULL
bp	NULL
of	NULL
the	NULL
IL-3	NULL
gene	NULL
promoter	NULL
(	NULL
pIL3luc	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
have	NULL
a	NULL
sequence	NULL
capable	NULL
of	NULL
forming	NULL
a	NULL
DNA	NULL
triplex	NULL
with	NULL
GM3	NULL
,	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
together	NULL
with	NULL
an	NULL
HTLV-1	NULL
tax	NULL
expression	NULL
vector	NULL
.	NULL

Both	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
promoter	NULL
activities	NULL
are	NULL
induced	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
(	NULL
38	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
TFO	NULL
GM3	NULL
and	NULL
control	NULL
oligomer	NULL
GMc	NULL
were	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
at	NULL
the	NULL
concentrations	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h	NULL
and	NULL
then	NULL
harvested	NULL
.	NULL

The	NULL
specific	NULL
triplex-forming	NULL
oligonucleotide	NULL
GM3	NULL
demonstrated	NULL
a	NULL
65	NULL
%	NULL
inhibition	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
activity	NULL
from	NULL
pGMluc	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
uM	NULL
,	NULL
whereas	NULL
no	NULL
effect	NULL
was	NULL
detected	NULL
when	NULL
cells	NULL
transfected	NULL
with	NULL
pGMluc	NULL
were	NULL
treated	NULL
with	NULL
GMe	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
1	NULL
um	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Also	NULL
no	NULL
significant	NULL
differences	NULL
in	NULL
luciferase	NULL
activity	NULL
induced	NULL
by	NULL
the	NULL
IL-3	NULL
promoter	NULL
were	NULL
detected	NULL
when	NULL
cells	NULL
transfected	NULL
with	NULL
pIL3luc	NULL
were	NULL
exposed	NULL
to	NULL
medium	NULL
alone	NULL
,	NULL
GM3	NULL
,	NULL
or	NULL
GMc	NULL
at	NULL
the	NULL
highest	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
Triplex	NULL
Formation	NULL
Inhibits	NULL
Transcription	NULL
from	NULL
the	NULL
Endogenous	NULL
GM-CSF	NULL
Gene-We	NULL
used	NULL
RNase	NULL
protection	NULL
assays	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
GM3	NULL
oligonucleotide	NULL
,	NULL
targeted	NULL
to	NULL
form	NULL
a	NULL
triple	NULL
helix	NULL
within	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
,	NULL
would	NULL
selectively	NULL
suppress	NULL
the	NULL
induction	NULL
of	NULL
mRNA	NULL
from	NULL
the	NULL
endogenous	NULL
GM-CSF	NULL
gene	NULL
.	NULL

The	NULL
effect	NULL
on	NULL
the	NULL
response	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
to	NULL
PMA/	NULL
Ca**	NULL
ionophore	NULL
treatment	NULL
and	NULL
HTLV-1	NULL
Tax	NULL
expression	NULL
in	NULL
combination	NULL
with	NULL
PMA/Ca®**	NULL
ionophore	NULL
was	NULL
measured	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
HTLV-1	NULL
tax	NULL
or	NULL
untransfected	NULL
were	NULL
preincubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
triplex-forming	NULL
oligonucleotide	NULL
GM3	NULL
or	NULL
control	NULL
oligomer	NULL
GMe	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

After	NULL
stimulation	NULL
for	NULL
a	NULL
further	NULL
7	NULL
h	NULL
with	NULL
PMA/Ca®**	NULL
ionophore	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
assayed	NULL
.	NULL

GM-CSF	NULL
mRNA	NULL
levels	NULL
in	NULL
PMA/Ca®*	NULL
ionophore-stimulated	NULL
cells	NULL
were	NULL
significantly	NULL
reduced	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
GM3	NULL
at	NULL
2.4	NULL
M	NULL
concentration	NULL
compared	NULL
with	NULL
samples	NULL
exposed	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
only	NULL
or	NULL
to	NULL
the	NULL
control	NULL
GMc	NULL
oligomer	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

GM3	NULL
was	NULL
also	NULL
effective	NULL
when	NULL
the	NULL
expression	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
was	NULL
synergistically	NULL
activated	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
and	NULL
PMA/Ca**	NULL
ionophore2	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

GM3	NULL
caused	NULL
up	NULL
to	NULL
70	NULL
%	NULL
reduction	NULL
of	NULL
the	NULL
GM-CSF	NULL
mRNA	NULL
level	NULL
induced	NULL
by	NULL
PMA/Ca**	NULL
ionophore	NULL
and	NULL
up	NULL
to	NULL
50	NULL
%	NULL
decrease	NULL
after	NULL
activation	NULL
with	NULL
HTLV-1	NULL
Tax	NULL
and	NULL
PMA/Ca**	NULL
ionophore	NULL
together	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Concentrations	NULL
of	NULL
immunoreactive	NULL
GM-CSF	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
cells	NULL
stimulated	NULL
with	NULL
both	NULL
stimuli	NULL
and	NULL
treated	NULL
with	NULL
GM3	NULL
,	NULL
but	NULL
not	NULL
GMc	NULL
,	NULL
were	NULL
also	NULL
decreased	NULL
by	NULL
an	NULL
average	NULL
45	NULL
%	NULL
with	NULL
the	NULL
highest	NULL
concentration	NULL
of	NULL
GM3	NULL
(	NULL
from	NULL
an	NULL
average	NULL
560	NULL
+	NULL
13	NULL
pg/ml	NULL
(	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL
)	NULL

to	NULL
an	NULL
average	NULL
320	NULL
+	NULL
16	NULL
pg/ml	NULL
in	NULL
two	NULL
experiments	NULL
)	NULL
in	NULL
accordance	NULL
with	NULL
mRNA	NULL
levels	NULL
in	NULL
the	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
same	NULL
cell	NULL
samples	NULL
,	NULL
concentrations	NULL
of	NULL
IL-3	NULL
mRNA	NULL
were	NULL
not	NULL
affected	NULL
either	NULL
by	NULL
TFO	NULL
GM3	NULL
or	NULL
by	NULL
control	NULL
GMc	NULL
oligonucleotides	NULL
regardless	NULL
of	NULL
the	NULL
type	NULL
of	NULL
activation	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
lead	NULL
to	NULL
the	NULL
conclusion	NULL
that	NULL
a	NULL
3'-amino	NULL
derivat-ized	NULL
oligodeoxyribonucleotide	NULL
,	NULL
directed	NULL
to	NULL
form	NULL
a	NULL
triple	NULL
helix	NULL
with	NULL
a	NULL
15-bp	NULL
target	NULL
sequence	NULL
overlapping	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
,	NULL
significantly	NULL
inhibits	NULL
transcription	NULL
from	NULL
the	NULL
endogenous	NULL
gene	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
inhibition	NULL
appears	NULL
to	NULL
be	NULL
oligomer-	NULL
and	NULL
gene-specific	NULL
.	NULL

DISCUSSION	NULL
We	NULL
show	NULL
here	NULL
that	NULL
a	NULL
triplex-forming	NULL
oligonucleotide	NULL
can	NULL
repress	NULL
transcription	NULL
from	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
*	NULL
Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Katsikeros	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1996	NULL
)	NULL
J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

Repression	NULL
of	NULL
GM-CSF	NULL
Transcription	NULL
by	NULL
DNA	NULL
Triple	NULL
Helix	NULL
125	NULL
3°	NULL
5	NULL
100	NULL
F3	NULL
2	NULL
§	NULL
75-|=	NULL
g	NULL
|	NULL
o	NULL
3	NULL
so-CC	NULL
€	NULL
0	NULL
2	NULL
25-K3	NULL
®	NULL
cC	NULL
o-Oligonucleotide	NULL
_	NULL
Nil	NULL
~-	NULL
ams	NULL
00	NULL
___	NULL
GMe	NULL
Conc	NULL
(	NULL
uM	NULL
)	NULL
0.6	NULL
1.1	NULL
2.4	NULL
-	NULL
2.4	NULL
HTLV-1	NULL
Tax	NULL
and	NULL
PMA/Ca	NULL
2+	NULL
lonophore	NULL
PMA/Ca	NULL
2+	NULL
lonophore	NULL
IL-3	NULL
I	NULL
E	NULL
|	NULL
HTLV-1	NULL
Tax	NULL
and	NULL
PMA/Ca	NULL
**	NULL
lonophore	NULL
PMA/Ca	NULL
2+	NULL
lonophore	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Triplex	NULL
formation	NULL
by	NULL
GM3	NULL
affects	NULL
expression	NULL
from	NULL
the	NULL
endogenous	NULL
GM-CSF	NULL
gene	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
activated	NULL
by	NULL
different	NULL
stimuli	NULL
.	NULL

Untransfected	NULL
Jurkat	NULL
T	NULL
cells	NULL
or	NULL
Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
peTax	NULL
were	NULL
treated	NULL
with	NULL
specific	NULL
TFO	NULL
GM3	NULL
or	NULL
control	NULL
GMe	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
and	NULL
stimulated	NULL
with	NULL
PMA/Ca®*	NULL
ionophore	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
purified	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
mRNAs	NULL
of	NULL
interest	NULL
were	NULL
assessed	NULL
by	NULL
PhosphorImager	NULL
quantitation	NULL
of	NULL
bands	NULL
,	NULL
obtained	NULL
from	NULL
mRNA	NULL
protection	NULL
by	NULL
*°P-labeled	NULL
antisense	NULL
probes	NULL
.	NULL

Glycer-aldehyde-3-phosphate	NULL
dehydrogenase	NULL
mRNA	NULL
levels	NULL
in	NULL
each	NULL
sample	NULL
were	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
reference	NULL
for	NULL
normalizing	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
mRNA	NULL
concentrations	NULL
.	NULL

The	NULL
columns	NULL
on	NULL
the	NULL
graph	NULL
represent	NULL
relative	NULL
levels	NULL
of	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
mRNA	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA/Ca®*	NULL
ionophore	NULL
or	NULL
HTLV-1	NULL
Tax	NULL
together	NULL
with	NULL
PMA/Ca®*	NULL
ionophore	NULL
.	NULL

GM-CSF	NULL
and	NULL
IL-3	NULL
mRNA	NULL
levels	NULL
in	NULL
cells	NULL
stimulated	NULL
and	NULL
not	NULL
treated	NULL
with	NULL
oligonucleotides	NULL
were	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
100	NULL
%	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
show	NULL
standard	NULL
deviations	NULL
of	NULL
the	NULL
results	NULL
obtained	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

human	NULL
GM-CSF	NULL
gene	NULL
promoter	NULL
and	NULL
more	NULL
importantly	NULL
can	NULL
reduce	NULL
expression	NULL
from	NULL
the	NULL
endogenous	NULL
GM-CSF	NULL
gene	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
show	NULL
that	NULL
GM-CSF	NULL
protein	NULL
concentrations	NULL
in	NULL
cell	NULL
supernatants	NULL
were	NULL
reduced	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
GM-CSF	NULL
mRNA	NULL
levels	NULL
.	NULL

Although	NULL
there	NULL
are	NULL
many	NULL
reports	NULL
of	NULL
triplex	NULL
formation	NULL
inhibiting	NULL
transcription	NULL
from	NULL
reporter	NULL
gene	NULL
constructs	NULL
,	NULL
only	NULL
a	NULL
few	NULL
reports	NULL
describe	NULL
the	NULL
inhibition	NULL
of	NULL
human	NULL
endogenous	NULL
gene	NULL
expression	NULL
in	NULL
cell	NULL
culture	NULL
(	NULL
17	NULL
,	NULL
40-42	NULL
)	NULL
.	NULL

The	NULL
TFO	NULL
binds	NULL
to	NULL
a	NULL
sequence	NULL
overlapping	NULL
a	NULL
«	NULL
kB	NULL
element	NULL
and	NULL
blocks	NULL
in	NULL
vitro	NULL
protein	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
previous	NULL
mutation	NULL
analysis	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
our	NULL
laboratory	NULL
showing	NULL
that	NULL
this	NULL
kB	NULL
element	NULL
is	NULL
required	NULL
for	NULL
the	NULL
response	NULL
of	NULL
the	NULL
promoter	NULL
to	NULL
PMA/Ca**	NULL
ionophore	NULL
activation	NULL
(	NULL
25	NULL
)	NULL
and	NULL
to	NULL
transactivation	NULL
by	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
(	NULL
27	NULL
)	NULL
in	NULL
reporter	NULL
gene	NULL
assays	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
confirm	NULL
these	NULL
results	NULL
for	NULL
the	NULL
endogenous	NULL
gene	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
by	NULL
PMA/Ca®*	NULL
ionophore	NULL
is	NULL
also	NULL
mediated	NULL
via	NULL
NFAT/AP-1	NULL
binding	NULL
sites	NULL
in	NULL
both	NULL
the	NULL
promoter	NULL
and	NULL
enhancer	NULL
(	NULL
25	NULL
,	NULL
43	NULL
)	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
requires	NULL
the	NULL
«	NULL
B	NULL
element	NULL
as	NULL
well	NULL
as	NULL
the	NULL
adjacent	NULL
CK-1	NULL
element	NULL
for	NULL
promoter	NULL
induction	NULL
but	NULL
does	NULL
not	NULL
activate	NULL
NFAT/AP-1	NULL
sites	NULL
(	NULL
27	NULL
)	NULL
.	NULL
``	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
GM3	NULL
TFO	NULL
inhibits	NULL
the	NULL
response	NULL
of	NULL
the	NULL
endogenous	NULL
gene	NULL
to	NULL
both	NULL
PMA/Ca**	NULL
ionophore	NULL
and	NULL
Tax/PMA/Ca**	NULL
ionophore	NULL
costimulation	NULL
suggests	NULL
a	NULL
central	NULL
role	NULL
for	NULL
this	NULL
kB	NULL
element	NULL
in	NULL
GM-CSF	NULL
gene	NULL
transcriptional	NULL
activation	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Repression	NULL
of	NULL
GM-CSF	NULL
Transcription	NULL
by	NULL
DNA	NULL
Triple	NULL
Helix	NULL
The	NULL
effect	NULL
of	NULL
the	NULL
TFO	NULL
GM3	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
the	NULL
GM-CSF	NULL
gene	NULL
and	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
IL-3	NULL
promoter	NULL
or	NULL
on	NULL
mRNA	NULL
levels	NULL
from	NULL
the	NULL
endogenous	NULL
IL-3	NULL
gene	NULL
.	NULL

The	NULL
gene	NULL
for	NULL
IL-3	NULL
responds	NULL
to	NULL
the	NULL
same	NULL
stimuli	NULL
as	NULL
GM-CSF	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
38	NULL
,	NULL
44	NULL
)	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
the	NULL
TFO	NULL
is	NULL
not	NULL
blocking	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
other	NULL
transcription	NULL
factor	NULL
function	NULL
in	NULL
general	NULL
but	NULL
is	NULL
acting	NULL
selectively	NULL
through	NULL
triplex	NULL
formation	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

It	NULL
is	NULL
also	NULL
worth	NULL
noting	NULL
that	NULL
the	NULL
GM3-targeted	NULL
DNA	NULL
sequence	NULL
covers	NULL
a	NULL
G/C	NULL
element	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
that	NULL
represents	NULL
a	NULL
putative	NULL
Sp1	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
Sp1	NULL
protein	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
numerous	NULL
genes	NULL
,	NULL
and	NULL
the	NULL
Sp1	NULL
site	NULL
was	NULL
found	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
murine	NULL
GM-CSF	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
G/C	NULL
region	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
has	NULL
a	NULL
2-bp	NULL
difference	NULL
with	NULL
the	NULL
functional	NULL
site	NULL
in	NULL
mouse	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
weak	NULL
Sp1	NULL
binding	NULL
site	NULL
.	NULL
``	NULL

However	NULL
,	NULL
blocking	NULL
of	NULL
Sp1	NULL
binding	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
by	NULL
the	NULL
TFO	NULL
may	NULL
also	NULL
contribute	NULL
to	NULL
the	NULL
observed	NULL
inhibitory	NULL
effect	NULL
of	NULL
GMB3	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

We	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
the	NULL
GM3	NULL
oligonucleotide	NULL
caused	NULL
a	NULL
slightly	NULL
greater	NULL
decrease	NULL
in	NULL
the	NULL
GM-CSF	NULL
mRNA	NULL
levels	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
induced	NULL
by	NULL
PMA/Ca**	NULL
ionophore	NULL
than	NULL
in	NULL
cells	NULL
activated	NULL
by	NULL
both	NULL
PMA/Ca®*	NULL
ionophore	NULL
and	NULL
the	NULL
HTLV-1	NULL
transac-tivator	NULL
Tax	NULL
.	NULL

Costimulation	NULL
of	NULL
GM-CSF	NULL
expression	NULL
by	NULL
these	NULL
two	NULL
stimuli	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
strong	NULL
synergistic	NULL
effect	NULL
leading	NULL
to	NULL
high	NULL
levels	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL
``	NULL

The	NULL
overexpression	NULL
of	NULL
Tax	NULL
significantly	NULL
increases	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
«	NULL
B	NULL
element	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
compared	NULL
with	NULL
that	NULL
seen	NULL
with	NULL
PMA/Ca**	NULL
ionophore	NULL
,	NULL
``	NULL
which	NULL
may	NULL
make	NULL
it	NULL
more	NULL
difficult	NULL
for	NULL
the	NULL
TFO	NULL
to	NULL
compete	NULL
with	NULL
proteins	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
target	NULL
site	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NFAT/AP-1	NULL
sites	NULL
and	NULL
the	NULL
CK-1	NULL
element	NULL
all	NULL
contribute	NULL
to	NULL
this	NULL
high	NULL
level	NULL
of	NULL
synergism	NULL
,	NULL
and	NULL
it	NULL
may	NULL
by	NULL
more	NULL
difficult	NULL
to	NULL
block	NULL
gene	NULL
activation	NULL
via	NULL
a	NULL
single	NULL
site	NULL
.	NULL

In	NULL
order	NULL
to	NULL
achieve	NULL
complete	NULL
inhibition	NULL
of	NULL
GM-CSF	NULL
transcription	NULL
it	NULL
may	NULL
be	NULL
necessary	NULL
to	NULL
use	NULL
TFOs	NULL
that	NULL
block	NULL
not	NULL
only	NULL
the	NULL
«	NULL
B	NULL
element	NULL
but	NULL
also	NULL
NFAT/AP-1	NULL
sites	NULL
in	NULL
the	NULL
gene	NULL
enhancer	NULL
or	NULL
promoter	NULL
since	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
all	NULL
of	NULL
these	NULL
elements	NULL
are	NULL
required	NULL
for	NULL
full	NULL
activation	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
25	NULL
,	NULL
27	NULL
,	NULL
43	NULL
)	NULL
.	NULL

It	NULL
may	NULL
be	NULL
also	NULL
possible	NULL
to	NULL
increase	NULL
the	NULL
affinity	NULL
of	NULL
TFO	NULL
binding	NULL
to	NULL
the	NULL
target	NULL
site	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

This	NULL
may	NULL
be	NULL
achieved	NULL
by	NULL
using	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
oligonucleotides	NULL
coupled	NULL
to	NULL
an	NULL
intercalating	NULL
agent	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
or	NULL
an	NULL
oligomer	NULL
that	NULL
is	NULL
linker-substituted	NULL
at	NULL
the	NULL
position	NULL
of	NULL
the	NULL
``	NULL
mismatch	NULL
``	NULL
in	NULL
the	NULL
duplex	NULL
target	NULL
(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
relatively	NULL
high	NULL
K	NULL
,	NULL
,	NULL
(	NULL
>	NULL
10	NULL
um	NULL
)	NULL
of	NULL
the	NULL
GM3	NULL
oligonucleotide	NULL
binding	NULL
to	NULL
its	NULL
duplex	NULL
target	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
one	NULL
mismatch	NULL
in	NULL
the	NULL
otherwise	NULL
homopurine-homopyrimidine	NULL
sequence	NULL
of	NULL
the	NULL
double-stranded	NULL
DNA	NULL
.	NULL

Pyrimidine	NULL
interruptions	NULL
in	NULL
the	NULL
purine	NULL
tract	NULL
of	NULL
the	NULL
targeted	NULL
DNA	NULL
sequence	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
significantly	NULL
unfavorable	NULL
for	NULL
triplex	NULL
formation	NULL
because	NULL
of	NULL
loss	NULL
of	NULL
Hoogsteen	NULL
hydrogen	NULL
bonding	NULL
(	NULL
21	NULL
)	NULL
and	NULL
can	NULL
increase	NULL
the	NULL
value	NULL
of	NULL
the	NULL
relative	NULL
binding	NULL
affinity	NULL
of	NULL
the	NULL
third	NULL
strand	NULL
by	NULL
approximately	NULL
1	NULL
order	NULL
of	NULL
magnitude	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
central	NULL
location	NULL
of	NULL
the	NULL
interruption	NULL
in	NULL
the	NULL
purine	NULL
sequence	NULL
of	NULL
the	NULL
du-plex	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
the	NULL
target	NULL
on	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
,	NULL
has	NULL
been	NULL
also	NULL
found	NULL
to	NULL
cause	NULL
greater	NULL
distortion	NULL
in	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
DNA	NULL
triplex	NULL
than	NULL
the	NULL
same	NULL
mismatch	NULL
situated	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
targeted	NULL
site	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Another	NULL
factor	NULL
that	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
relatively	NULL
low	NULL
affinity	NULL
of	NULL
GM3	NULL
for	NULL
its	NULL
target	NULL
DNA	NULL
is	NULL
the	NULL
stretch	NULL
of	NULL
eight	NULL
consecutive	NULL
guanines	NULL
in	NULL
the	NULL
TFO	NULL
,	NULL
which	NULL
makes	NULL
this	NULL
oligonucleotide	NULL
highly	NULL
susceptible	NULL
to	NULL
self-aggregation	NULL
through	NULL
the	NULL
formation	NULL
of	NULL
G-tetrades	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
.	NULL

It	NULL
also	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
some	NULL
degradation	NULL
of	NULL
the	NULL
triplex	NULL
may	NULL
occur	NULL
during	NULL
the	NULL
course	NULL
of	NULL
electrophoresis	NULL
,	NULL
thus	NULL
increasing	NULL
the	NULL
value	NULL
of	NULL
the	NULL
K	NULL
)	NULL
,	NULL
observed	NULL
.	NULL

In	NULL
a	NULL
number	NULL
of	NULL
previous	NULL
studies	NULL
it	NULL
has	NULL
been	NULL
noted	NULL
that	NULL
the	NULL
*P.	NULL
Cockerill	NULL
,	NULL
personal	NULL
communication	NULL
.	NULL

14448	NULL
extracellular	NULL
concentration	NULL
of	NULL
the	NULL
TFO	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
target	NULL
gene	NULL
transcription	NULL
in	NULL
intact	NULL
cells	NULL
was	NULL
in	NULL
the	NULL
range	NULL
of	NULL
10-25	NULL
um	NULL
(	NULL
17	NULL
,	NULL
18	NULL
,	NULL
40	NULL
)	NULL
,	NULL
which	NULL
was	NULL
10-50	NULL
times	NULL
the	NULL
dissociation	NULL
constant	NULL
for	NULL
triplex	NULL
formation	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
study	NULL
are	NULL
not	NULL
consistent	NULL
with	NULL
these	NULL
observations	NULL
.	NULL

A	NULL
significant	NULL
decrease	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
levels	NULL
by	NULL
GM3	NULL
was	NULL
achieved	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2.4	NULL
um	NULL
of	NULL
the	NULL
TFO	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
,	NULL
which	NULL
was	NULL
below	NULL
the	NULL
K	NULL
;	NULL
,	NULL
value	NULL
observed	NULL
in	NULL
the	NULL
binding	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

This	NULL
may	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
intrinsic	NULL
properties	NULL
of	NULL
the	NULL
GM3	NULL
oligonucleotide	NULL
sequence	NULL
.	NULL

But	NULL
this	NULL
finding	NULL
may	NULL
also	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
possible	NULL
changes	NULL
in	NULL
the	NULL
chromatin	NULL
structure	NULL
upon	NULL
activation	NULL
of	NULL
the	NULL
inducible	NULL
GM-CSF	NULL
gene	NULL
that	NULL
could	NULL
make	NULL
the	NULL
target	NULL
duplex	NULL
in	NULL
the	NULL
gene	NULL
promoter	NULL
more	NULL
easily	NULL
accessible	NULL
for	NULL
the	NULL
exogenous	NULL
oligonucleotide	NULL
and	NULL
thus	NULL
promote	NULL
more	NULL
efficient	NULL
triplex	NULL
formation	NULL
by	NULL
GM3	NULL
.	NULL

50-70	NULL
%	NULL
of	NULL
cases	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
depend	NULL
on	NULL
GM-CSF	NULL
for	NULL
proliferation	NULL
both	NULL
in	NULL
vitro	NULL
(	NULL
8	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
9	NULL
)	NULL
and	NULL
also	NULL
for	NULL
engraftment	NULL
into	NULL
SCID	NULL
mice	NULL
(	NULL
53	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
antagonist	NULL
of	NULL
GM-CSF/receptor	NULL
interactions	NULL
can	NULL
block	NULL
the	NULL
growth	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
in	NULL
vitro	NULL
(	NULL
54	NULL
)	NULL
,	NULL
as	NULL
can	NULL
antibodies	NULL
against	NULL
GM-CSF	NULL
(	NULL
55	NULL
)	NULL
and	NULL
its	NULL
receptor	NULL
(	NULL
56	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
that	NULL
paracrine	NULL
production	NULL
of	NULL
GM-CSF	NULL
is	NULL
responsible	NULL
for	NULL
progression	NULL
of	NULL
the	NULL
disease	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
20-30	NULL
%	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
cases	NULL
constitutively	NULL
produce	NULL
and	NULL
respond	NULL
to	NULL
GM-CSF	NULL
(	NULL
39	NULL
,	NULL
58	NULL
,	NULL
59	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
can	NULL
also	NULL
act	NULL
in	NULL
an	NULL
autocrine	NULL
manner	NULL
.	NULL

The	NULL
GM3	NULL
TFO	NULL
may	NULL
,	NULL
therefore	NULL
,	NULL
have	NULL
a	NULL
potential	NULL
therapeutic	NULL
role	NULL
in	NULL
blocking	NULL
either	NULL
the	NULL
paracrine	NULL
or	NULL
autocrine	NULL
production	NULL
of	NULL
GM-CSF	NULL
in	NULL
cases	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
in	NULL
the	NULL
bronchoalveolar	NULL
lavage	NULL
of	NULL
atopic	NULL
patients	NULL
and	NULL
GM-CSF	NULL
protein	NULL
in	NULL
the	NULL
synovial	NULL
fluid	NULL
of	NULL
rheumatoid	NULL
arthritis	NULL
patients	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
suggests	NULL
another	NULL
role	NULL
for	NULL
the	NULL
therapeutic	NULL
use	NULL
of	NULL
TFOs	NULL
that	NULL
block	NULL
GM-CSF	NULL
transcription	NULL
.	NULL

Acknowledgments-We	NULL
gratefully	NULL
acknowledge	NULL
Dr.	NULL
Roy	NULL
Himes	NULL
for	NULL
the	NULL
pGMluc	NULL
plasmid	NULL
,	NULL
Dr.	NULL
Peter	NULL
Cockerill	NULL
for	NULL
the	NULL
plL3lue	NULL
plasmid	NULL
,	NULL
Dr.	NULL
Steve	NULL
Gerondakis	NULL
for	NULL
the	NULL
recombinant	NULL
p65	NULL
protein	NULL
,	NULL
and	NULL
Dr.	NULL
Tim	NULL
Hercus	NULL
for	NULL
performing	NULL
the	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Professors	NULL
Angel	NULL
Lopez	NULL
and	NULL
Mathew	NULL
Vadas	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
helpful	NULL
comments	NULL
.	NULL

REFERENCES	NULL
.	NULL

Henderson	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Blake	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Trends	NULL
Pharmacol	NULL
.	NULL

Sci	NULL
.	NULL

18	NULL
,	NULL
145-152	NULL
.	NULL

Nicola	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58	NULL
,	NULL
45-77	NULL
.	NULL

Gasson	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1131-1145	NULL
.	NULL

Kato	NULL
,	NULL
M.	NULL
,	NULL
Liu	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Stealey	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Friedman	NULL
,	NULL
B.	NULL
,	NULL
Lichtenstein	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Permutt	NULL
,	NULL
S.	NULL
&	NULL
Schleimer	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
Lymphokine	NULL
Cytokine	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
287-292	NULL
5	NULL
.	NULL

Williamcon	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
Vadas	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

72	NULL
,	NULL
67-173	NULL
6	NULL
.	NULL

Pebusque	NULL
,	NULL
M-J	NULL
.	NULL

,	NULL
Lopez	NULL
,	NULL
M.	NULL
,	NULL
Torres	NULL
,	NULL
H.	NULL
,	NULL
Carotty	NULL
,	NULL
A.	NULL
,	NULL
Guilbert	NULL
,	NULL
L.	NULL
&	NULL
Mannoni	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

16	NULL
,	NULL
360-366	NULL
7	NULL
.	NULL

Vellenga	NULL
,	NULL
E.	NULL
,	NULL
Delwel	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Touw	NULL
,	NULL
I.	NULL
P.	NULL
&	NULL
Lowenberg	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

15	NULL
,	NULL
652-656	NULL
8	NULL
.	NULL

Budel	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Touw	NULL
,	NULL
I.	NULL
P.	NULL
,	NULL
Delwel	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Clark	NULL
,	NULL
S.	NULL
C.	NULL
&	NULL
Lowenberg	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
545-549	NULL
9	NULL
.	NULL

Estrov	NULL
,	NULL
Z.	NULL
,	NULL
Estey	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
Andreeff	NULL
,	NULL
M.	NULL
,	NULL
Talpaz	NULL
,	NULL
M.	NULL
,	NULL
Kurzrock	NULL
,	NULL
T.	NULL
,	NULL
Reading	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Deisseroth	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

&	NULL
Gutterman	NULL
,	NULL
J.	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

20	NULL
,	NULL
558-564	NULL
10	NULL
.	NULL

Stull	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

&	NULL
Szoka	NULL
,	NULL
F.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Pharm	NULL
.	NULL

Res	NULL
.	NULL

(	NULL
N	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

12	NULL
,	NULL
465-483	NULL
11	NULL
.	NULL

Hélene	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Anti-Cancer	NULL
Drug	NULL
Design	NULL
6	NULL
,	NULL
569-584	NULL
12	NULL
.	NULL

Maher	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Wold	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Science	NULL
245	NULL
,	NULL
725-730	NULL
13	NULL
.	NULL

Maher	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
III	NULL
(	NULL
1992	NULL
)	NULL
Biochemistry	NULL
81	NULL
,	NULL
7587-7594	NULL
14	NULL
.	NULL

Samadashwily	NULL
,	NULL
G.	NULL
M.	NULL
&	NULL
Mirkin	NULL
,	NULL
S.	NULL
M	NULL
(	NULL
1994	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

149	NULL
,	NULL
127-136	NULL
15	NULL
.	NULL

Mayfield	NULL
,	NULL
C.	NULL
,	NULL
Ebbinghaus	NULL
,	NULL
S.	NULL
,	NULL
Gee	NULL
,	NULL
J.	NULL
,	NULL
Jones	NULL
,	NULL
D.	NULL
,	NULL
Rodu	NULL
,	NULL
B.	NULL
,	NULL
Squibb	NULL
,	NULL
M.	NULL
&	NULL
Miller	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
18232-18238	NULL
16	NULL
.	NULL

Grigoriev	NULL
,	NULL
M.	NULL
,	NULL
Praseuth	NULL
,	NULL
D.	NULL
,	NULL
Guieysse	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Robin	NULL
,	NULL
P.	NULL
,	NULL
Thuong	NULL
,	NULL
N.	NULL
T.	NULL
,	NULL
Héléne	NULL
,	NULL
C.	NULL
&	NULL
Harrel-Bellan	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
3501-8505	NULL
17	NULL
.	NULL

Orson	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Thomas	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
McShan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Kesler	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

&	NULL
Hogan	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
3485-3441	NULL
18	NULL
.	NULL

Roy	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

220	NULL
,	NULL
493-503	NULL
19	NULL
.	NULL

Le	NULL
Doan	NULL
,	NULL
T.	NULL
,	NULL
Perrouault	NULL
,	NULL
L.	NULL
,	NULL
Praseuth	NULL
,	NULL
D.	NULL
,	NULL
Habhoub	NULL
,	NULL
N.	NULL
,	NULL
Decout	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Thuong	NULL
,	NULL
N.	NULL
T.	NULL
,	NULL
Lhomme	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Héléne	NULL
,	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
7749-7760	NULL
20	NULL
.	NULL

Moser	NULL
,	NULL
H.	NULL
E.	NULL
&	NULL
Dervan	NULL
,	NULL
P	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Science	NULL
288	NULL
,	NULL
645-650	NULL
21	NULL
.	NULL

Beal	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
251	NULL
,	NULL
1360-1363	NULL
22	NULL
.	NULL

Povsic	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Chem	NULL
.	NULL

Soc	NULL
.	NULL

111	NULL
,	NULL
3059-3061	NULL
23	NULL
.	NULL

Strobel	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

&	NULL
Dervan	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
850	NULL
,	NULL
172-174	NULL
24	NULL
.	NULL

Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Bert	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Ryan	NULL
,	NULL
G.	NULL
R.	NULL
&	NULL
Vadas	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
2466-2470	NULL
25	NULL
.	NULL

Jenkins	NULL
,	NULL
F.	NULL
,	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Bohmann	NULL
,	NULL
D.	NULL
&	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immu-	NULL
>	NULL
to	NULL
bo	NULL
1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
14444	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
nol	NULL
.	NULL

155	NULL
,	NULL
1240-1251	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Himes	NULL
,	NULL
S.	NULL
R.	NULL
&	NULL
Coles	NULL
,	NULL
L.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

57	NULL
,	NULL
767-773	NULL
Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Coles	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Katsikeros	NULL
,	NULL
R.	NULL
,	NULL
Lang	NULL
,	NULL
R.	NULL
K.	NULL
&	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Oncogene	NULL
8	NULL
,	NULL
3189-3197	NULL
Smith	NULL
,	NULL
M.	NULL
T.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1875-1885	NULL
Maxam	NULL
,	NULL
A.	NULL
M.	NULL
&	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1980	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

65	NULL
,	NULL
499-560	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419-6421	NULL
Wood	NULL
,	NULL
K.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Chemiluminescence	NULL
:	NULL
Current	NULL
Status	NULL
(	NULL
Stanley	NULL
,	NULL
P.	NULL
&	NULL
Cricka	NULL
,	NULL
L.	NULL
,	NULL
eds	NULL
)	NULL
p.	NULL
543	NULL
,	NULL
John	NULL
Wiley	NULL
and	NULL
Sons	NULL
Ltd.	NULL
,	NULL
Chichester	NULL
,	NULL
United	NULL
Kingdom	NULL
Goodall	NULL
,	NULL
G.	NULL
&	NULL
Filipowicz	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
473-483	NULL
Durland	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Kessler	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Gunnell	NULL
,	NULL
M.	NULL
,	NULL
Duvic	NULL
,	NULL
M.	NULL
,	NULL
Pettitt	NULL
,	NULL
B.	NULL
M.	NULL
&	NULL
Hogan	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Biochemistry	NULL
80	NULL
,	NULL
9246-9255	NULL
McShan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Rossen	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Laughter	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Trial	NULL
,	NULL
J.	NULL
,	NULL
Kessler	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Zendegui	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Hogan	NULL
,	NULL
M.	NULL
E.	NULL
&	NULL
Orson	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
5712-5721	NULL
Sun	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
DeBigemont	NULL
,	NULL
T.	NULL
,	NULL
Duval-Valentin	NULL
,	NULL
T.	NULL
,	NULL
Montenay-Garestier	NULL
,	NULL
T.	NULL
&	NULL
Hélene	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Comptes	NULL
Rend	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

Paris	NULL
,	NULL
Série	NULL
III	NULL
818	NULL
,	NULL
585-590	NULL
Holt	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Redner	NULL
,	NULL
R.	NULL
L.	NULL
&	NULL
Nienhuis	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
963-973	NULL
Akhtar	NULL
,	NULL
S.	NULL
&	NULL
Juliano	NULL
.	NULL

R.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

2	NULL
,	NULL
139-144	NULL
Wano	NULL
,	NULL
Y.	NULL
,	NULL
Feinberg	NULL
,	NULL
M.	NULL
,	NULL
Hosking	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
&	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
9733-9737	NULL
Reily	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
Kozlowski	NULL
,	NULL
R.	NULL
&	NULL
Russell	NULL
,	NULL
N.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Brit	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

72	NULL
,	NULL
363-369	NULL
Postel	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Flint	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Kessler	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

&	NULL
Hogan	NULL
,	NULL
M.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
8227-8231	NULL
Tu	NULL
,	NULL
G.-C.	NULL
,	NULL
Cao	NULL
,	NULL
Q.-N.	NULL
&	NULL
Israel	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
28402-28407	NULL
Thomas	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Faaland	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Gallo	NULL
,	NULL
M.	NULL
&	NULL
Chomas	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

28	NULL
,	NULL
3594-3599	NULL
Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Bert	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Jenkins	NULL
,	NULL
F.	NULL
,	NULL
Ryan	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
&	NULL
Vadas	NULL
,	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

Repression	NULL
of	NULL
GM-CSF	NULL
Transcription	NULL
by	NULL
DNA	NULL
Triple	NULL
Helix	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
2071-2079	NULL
Miatake	NULL
,	NULL
S.	NULL
,	NULL
Seiki	NULL
,	NULL
M.	NULL
,	NULL
Malefijit	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Heiki	NULL
,	NULL
T.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J-L.	NULL
,	NULL
Takabe	NULL
,	NULL
L.	NULL
Y.	NULL
K.	NULL
,	NULL
Nishida	NULL
,	NULL
J.	NULL
,	NULL
Shlomai	NULL
,	NULL
J.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
Arai	NULL
,	NULL
K-I	NULL
.	NULL

&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
6547-6566	NULL
Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Yamaguchi-Iwai	NULL
,	NULL
Y.	NULL
,	NULL
Tsuboi	NULL
,	NULL
A.	NULL
,	NULL
Hung	NULL
,	NULL
P.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
&	NULL
Arai	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

205	NULL
,	NULL
1518-1525	NULL
Grigoriev	NULL
,	NULL
M.	NULL
,	NULL
Praseuth	NULL
,	NULL
D.	NULL
,	NULL
Robin	NULL
,	NULL
P.	NULL
,	NULL
Hemar	NULL
,	NULL
A.	NULL
,	NULL
Saison-Behmoaras	NULL
,	NULL
T.	NULL
,	NULL
Dautry-Varsat	NULL
,	NULL
A.	NULL
,	NULL
Thuong	NULL
,	NULL
N.	NULL
T.	NULL
,	NULL
Hélene	NULL
,	NULL
C.	NULL
&	NULL
Harel-Bellan	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
3389-3395	NULL
Wilson	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
Tanious	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
Mizan	NULL
,	NULL
S.	NULL
,	NULL
Yao	NULL
,	NULL
S.	NULL
,	NULL
Kiselyov	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Zon	NULL
,	NULL
G.	NULL
&	NULL
Strekowski	NULL
,	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
Biochemistry	NULL
82	NULL
,	NULL
10614-10621	NULL
Mayfield	NULL
,	NULL
C.	NULL
&	NULL
Miller	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
1909-1916	NULL
Mergny	NULL
,	NULL
J-L.	NULL
,	NULL
Sun	NULL
,	NULL
J-8	NULL
.	NULL

,	NULL
Rougée	NULL
,	NULL
M.	NULL
,	NULL
Montenay-Garestier	NULL
,	NULL
T.	NULL
,	NULL
Barcelo	NULL
,	NULL
F.	NULL
,	NULL
Chomilier	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Héléne	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Biochemistry	NULL
80	NULL
,	NULL
9791-9798	NULL
Cheng	NULL
,	NULL
A-J	NULL
.	NULL

&	NULL
Van	NULL
Dyke	NULL
,	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
4742-4747	NULL
Olivas	NULL
,	NULL
W.	NULL
M.	NULL
&	NULL
Maher	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
III	NULL
(	NULL
1995	NULL
)	NULL
Biochemistry	NULL
34	NULL
,	NULL
278-284	NULL
Guschlbauer	NULL
,	NULL
W.	NULL
,	NULL
Chantot	NULL
,	NULL
J.-F.	NULL
&	NULL
Thiele	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biomol	NULL
.	NULL

Struct	NULL
.	NULL

Dyn	NULL
.	NULL

8	NULL
,	NULL
491-521	NULL
Lapidot	NULL
,	NULL
T.	NULL
,	NULL
Sirard	NULL
,	NULL
C.	NULL
,	NULL
Vormoor	NULL
,	NULL
J.	NULL
,	NULL
Murdich	NULL
,	NULL
B.	NULL
,	NULL
Hoang	NULL
,	NULL
T.	NULL
,	NULL
Caceres-Cortes	NULL
,	NULL
J.	NULL
,	NULL
Minden	NULL
,	NULL
M.	NULL
,	NULL
Paterson	NULL
,	NULL
B.	NULL
,	NULL
Callglur	NULL
]	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Dick	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
867	NULL
,	NULL
645-648	NULL
Hercus	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Bagley	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Cambareri	NULL
,	NULL
B.	NULL
,	NULL
Dottore	NULL
,	NULL
M.	NULL
,	NULL
Woodcock	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Vadas	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Shannon	NULL
,	NULL
M.	NULL
F.	NULL
&	NULL
Lopez	NULL
,	NULL
A.	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
5838-5842	NULL
Freedman	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Cohen	NULL
,	NULL
A.	NULL
,	NULL
Grunberger	NULL
,	NULL
T.	NULL
,	NULL
Bunin	NULL
,	NULL
N.	NULL
,	NULL
Luddy	NULL
,	NULL
R.	NULL
,	NULL
Saunders	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Shahidi	NULL
,	NULL
N.	NULL
,	NULL
Lau	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Estrov	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Brit	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

80	NULL
,	NULL
40-48	NULL
Nicola	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Wycherley	NULL
,	NULL
K.	NULL
,	NULL
Boyd	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Layton	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Cary	NULL
,	NULL
D.	NULL
&	NULL
Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
1724-1731	NULL
Metcalf	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Blood	NULL
67	NULL
,	NULL
257-267	NULL
Young	NULL
,	NULL
D.	NULL
C.	NULL
&	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Blood	NULL
68	NULL
,	NULL
1178-1181	NULL
Russell	NULL
,	NULL
N.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
Rev	NULL
.	NULL

6	NULL
,	NULL
149-156	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
DNA	NULL
Triplex	NULL
Formation	NULL
Selectively	NULL
Inhibits	NULL
Granulocyte-Macrophage	NULL
Colony-stimulating	NULL
Factor	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
T	NULL
Cells	NULL
Marina	NULL
Kochetkova	NULL
and	NULL
M.	NULL
Frances	NULL
Shannon	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:14438-14444.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.24.14438	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/24/1	NULL
4438	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
58	NULL
references	NULL
,	NULL
20	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
4438.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

